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Abstract 
We set out to understand the precise mechanisms that regulate the activation and 
deactivation of Cullin-RING Ligases (CRLs). While a great deal of work has already 
gone into identifying the players involved in these pathways and the cellular 
consequences associated with the loss of each, the biochemical mechanisms regulating 
these steps have remained elusive. In this work we sought to gain a better understanding 
of the mechanisms behind these steps by teasing apart specific their biochemical 
reactions. By measuring the individual microscopic rate constants of the reactions we 
have shed light on both the proper sequence of events in the regulation of CRLs as well 
as how they are in fact controlled.   
 Prior to this work, it was believed that CSN deactivated CRLs by binding them 
and enzymatically removing the activating post-translation modification Nedd8. It was 
believed that CSN could not bind to CRLs while they were active due to the steric 
hindrance by the CRL substrates, and that they would remain bound to deneddylated 
CRLs as a sequestering agent until a new substrate could displace it. We now have some 
insight that substrates themselves cannot inhibit CSN very well, but that the active 
ubiquitination by an E2 enzyme precludes CSN binding and activity. When the substrate 
for a CRL becomes depleted, CSN then binds to the CRL in a low affinity, low activity 
conformation. This triggers a conformational change that pulls the autoinhibitory Ins-1 
loop away from the active site in the catalytic subunit Csn5, resulting in a large increase 
in affinity and cleavage of the isopeptide bond between CRLs and Nedd8. Upon 
dissociation of Nedd8, CSN rapidly returns to the low affinity state and dissociates from 
the CRL, allowing it reenter its activation cycle.
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Ubiquitin Proteasome System 
The cell, regardless of being a complete organism or part of one, comprises 
several basic components.  The simplistic view of biologists midway through the last 
century was that these basic components were 1) nucleic acids, records and messages of 
the genetic code; 2) proteins that provide the internal skeleton of a cell, transmit 
messages, and carry out catalytic functions; and 3) lipids, which serve as boundaries of 
the cell and hold the contents within a structure separated from the outside world. 
Although these early functions of the basic components have been validated, the true 
complexity of the cell has turned out to be much more complicated than early biologists 
could have imagined.  
 One cataclysmic change that occurred in the field was in our understanding of the 
fate and stability of cellular proteins. It was thought that proteins within a cell were 
subject to regulation by transcription, and that once they were made they were relatively 
stable. The common belief at this time was that these newly transcribed proteins would 
remain stable in the cell until they were damaged. This of course, could not be the way 
that things function, given our current understanding of cell biology. There are many 
proteins, such as the cyclins, that directly regulate the cell cycle. When they are present 
they allow certain activities to occur which help progress the cell to the next stage of the 
cell cycle. We understand now that such signals, if left uninhibited, would cause the cell 
to replicate and divide over and over, and result in an uncontrolled expansion of cell 
number. This would either result in the organism growing exponentially throughout its 
life or, through a mechanism controlled by chromosomal telomeres, lead to premature 
senescence of cells and a shortened life span. Of course, cells do not replicate ad 
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infinitum, a process regulated by both controlling the activity of such proteins, as well as 
degrading them entirely.  
 In Eukaryotic cells, one mechanism that carries out the function of degrading 
proteins is the ubiquitin–proteasome system (UPS) (Deshaies and Joazeiro 2009). The 
UPS constitutes an elegant cascade of events, which target specific proteins within the 
cellular milieu for destruction by the covalent conjugation of the small protein ubiquitin. 
Ubiquitinated proteins are recognized by a massive protein complex, the proteasome, 
which degrades the said protein into its constituent amino acids. The UPS can be readily 
be broken down into two processes: 1) Ubiquitination, in which a ubiquitin molecule is 
covalently attached to a protein, and 2) proteasomal degradation, which uses three 
different protease active sites encased within a cylindrical chamber to degrade the 
specific subset of the ubiquitinated proteinz. The most universally accepted definition of 
a proteasome substrate is a protein tagged with a chain of four or more ubiquitins 
connected to each other through lysine 48 or lysine 11 of one ubiquitin and the C-
terminus of another.  
Ubiquitin 
 The ubiquitin molecule is a very simple yet extraordinary precise signal that is 
utilized by the cell for a variety of functions. Ubiquitin is a 76 amino acid protein 
expressed from four different genes as polyubiquitins or ribosomal protein fusions . 
Through the function of USPs free ubiquitin is formed from these polyproteins. The free 
ubiquitin can then be conjugated to an acceptor lysine’s ε-amino group on the target 
protein through its C-terminal glycine’s carboxylic acid group forming an isopeptide 
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bond. The result of this reaction will be a monoubiquitinated protein (Komander and 
Rape 2012). 
Analogous to phosphorylation, many signaling functions of the cell are carried out 
by the attachment of a single ubiquitin molecule. In addition, more ubiquitin molecules 
can be attached to the first ubiquitin on a variety of lysines to form a chain. Chain 
formation through different lysines on ubiquitin can yield topologically distinct signals. 
Chains formed by linkages through specific lysines have been shown to carry out unique 
signaling functions by binding different classes of receptors (Komander and Rape 2012). 
For example, proteasomal degradation is thought to depend on proteasome receptors 
binding to K48- or K11-linked ubiquitin chains, whereas K63-linked chains have been 
shown to functions as nondestructive signals for a variety of cellular processes.  
Although ubiquitin has been implicated in a variety of diseases, ubiquitin itself 
has not been shown to be a causative agent. There is, however, some evidence that the 
UBB+1 form of ubiquitin has been associated with tauopathies and polyglutamine 
diseases. The UBB+1 protein is formed by the molecular misreading that yields a frame 
shift mutation in the translated protein (Dennissen, Kholod et al. 2011). 
 In addition to ubiquitin, there are a variety of other ubiquitin-like molecules that 
use very similar mechanisms as the ubiquitin cascade. Under certain conditions, these 
proteins can replace each other and enter each other’s cascades. It remains to be 
determined whether or not this phenomenon is physiologically relevant.  
E1 – Ubiquitin Activating Enzyme 
After the formation of monomeric ubiquitin molecules, the initial step in 
activating the ubiquitination cascade starts with an E1 enzyme.  E1 proteins are known as 
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ubiquitin activating enzymes because they utilize the energy of ATP to form a covalent 
thioester bond to the C-terminal carboxyl group of the ubiquitin. This newly activated 
ubiquitin can now be moved along the cascade using the energy of its thioester to be 
conjugated to proteins (Schulman and Harper 2009). 
 In mammalian cells, there are at least two E1 enzymes capable of activating 
ubiquitin in vitro, implying that there is some degree of redundancy. Ube1 is the main 
gene thought to carry out this function in vivo, since many of the other related proteins 
have been shown to predominantly carry out their functions on other ubiquitin-like 
proteins. Uba6 is another E1 enzyme has been proposed to be an E1 under certain 
conditions, although later work showed that its preferred substrate is the Ubl FAT10. It 
remains to be seen which other E1s are true ubiquitin activating enzymes in vivo and 
what roles they play in cellular biology.  
 To date, genetic analysis of Ube1, the sole strict ubiquitin E1 enzymes, has 
revealed a role in one disease. Three separate mutations in exon 15 of UBE1 have been 
shown to cause X-linked Infantile Spinal Muscular Atrophy (XL-SMA) (Nouspikel and 
Hanawalt 2006). The fact that these mutations are fatal during the infantile period shows 
that, despite the possible redundancy, the activation of the ubiquitination cascade by 
Ube1 is critical to human development.  
E2-Ubiquitin Conjugating Enzymes 
After activating an ubiquitin molecule with ATP, the E1 enzyme will pass the 
ubiquitin along to a variety of E2 ubiquitin conjugating enzymes. This is accomplished 
by transferring ubiquitin from the E1 to the active cysteine of the E2. Once the ubiquitin 
has been loaded onto the E2 enzyme, the E2 can interact with a partner E3 to transfer the 
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ubiquitin to a substrate. See below for more detail about the interaction between E2s and 
E3s. This cycle can occur once or be repeated many times and lead to a polyubiquitinated 
substrate (van Wijk and Timmers 2010). 
Although many known E2 enzymes form K48 linked chains, E2s can facilitate 
other types of linkages. For example, Ubc13 is known to form K63 linked ubiquitin 
chains. All in all, mammalian cells have at least 35 active E2 proteins to carry out 
conjugation of ubiquitin as well as the other UBLs. 
E3 – Ubiquitin Ligases 
A common theme in the ubiquitination cascade is that the further you move along, 
the more players are involved.  Moving from a single E1 to initiate the activation of 
ubiquitin molecule to its final attachment as a post-translation modification on a large 
number of proteins within a cell requires a great deal of specificity. Much of this 
specificity is derived from the E3 ubiquitin ligases. The E3 ligases can be subdivided into 
two groups based on domain homology: HECT domain E3 ligases and RING-finger, or 
RING domain, E3 Ligases. Because E3 ligases serve to deliver ubiquitin to terminal 
substrates, some of which are non-essential, they tend to be intricately involved in many 
diseases when they are deleted or functionally impaired.  In the absence of E3 ligases, 
proteins can accumulate inappropriately and impair the cell’s ability to signal, or in some 
cases, form insoluble aggregates within cells (Popovic, Vucic et al. 2014).  
 When one thinks of the typical ubiquitination cascade in which the ubiquitin is 
sequentially passed along the E1, E2, E3, and finally to the substrate, it is typically one 
that involves a HECT domain E3 Ligase. HECT domain ligases, (HECT: Homologus to 
E6-AP Carboxyl Terminus), accept the ubiquitin molecule to form a third thioester from 
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their cognate E2. The ubiquitin molecule is then transferred to the lysine of a substrate 
bound directly to or in a complex with the E3 enzymes. Through this direct transfer of 
ubiquitin, the specificity of the ubiquitin chain linkage can be decided by the E3 ligase 
since the E2 protein is not involved in the process after the thioester transfer to the E3 
(Kim and Huibregtse 2009).   
 RING domain E3 ligases, in contrast, never covalently bind the ubiquitin 
molecule.  RING domain E3s serve two distinct functions in the final conjugation of 
ubiquitin to their substrates: 1) they activate the E2 enzyme to more readily transfer its 
covalently bound ubiquitin to the substrate, and 2) they bring the substrate in close 
proximity to the E2 so that the transfers can readily occur. As opposed to being an active 
intermediate in the chemical reaction, RING domain E3 ligases serve as scaffolds 
between E2s and substrates to mediate the transfer of ubiquitin.  
 RING (Really Interesting New Gene ) domain proteins, were first described in the 
early 1990’s as a class of proteins with conserved cysteine and histidine residues 
organized in semi-symmetric units, which selectively bind two zinc atoms. Although 
proteins of the RING domain family appeared to look very much like zinc finger proteins 
and were postulated to be involved in DNA binding, the length of the loop between the 
two zinc binding domains excludes this possibility. In the time since, the family of RING 
proteins has grown from the 27 originally defined to over 300 members in the human 
genome (Deshaies and Joazeiro 2009). 
  Although RING domains are fairly heterogeneous and one cannot make hard and 
fast rules, the RING domain appears to be the predominant binding site for the incoming 
E2 ubiquitin conjugating enzymes. Further studies have show that RING domains do not 
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just serve as the binding domain for E2s, but can in fact increase the activity of E2s 
(Deshaies and Joazeiro 2009). 
 A large number of diseases are caused by mutations in E3 ligases, and it is beyond 
the scope of this thesis to list them all. Whereas we see very few diseases caused by 
mutations in the early steps of the ubiquitination cascade, the phenomenon of E3 proteins 
being directly linked to diseases probably occurs because they are more specific for 
smaller subsets of substrates than E1, E2s, or ubiquitin itself. This is evidenced by the 
fact that not all E3s are essential to life and there can be a certain level or redundancy for 
the degradation of very critical substrates, such as c-myc, a powerful proto-oncogene 
when not properly regulated (Skaar, Pagan et al. 2013).  
Cullin-RING Ligases 
 Within the larger family of RING domain ligases there is a subset of E3 ligases 
defined by a scaffold protein containing cullin homology repeats that functions as a 
heterodimer with one of the RING domain protein, Rbx1 or Rbx2. Cullins 1, 2, 3, 4A and 
4B are always found as a stable heterodimer with Rbx1 bound to their C-terminal 
domain, while Cul5 is always bound to Rbx2. The cullins are typical RING ligases in the 
sense that they use their RING subunit to recruit and activate the E2 enzymes to directly 
transfer ubiquitins to the substrate. They also function like other RINGs E3 ligases 
because they essentially serve as a scaffold to organize substrates and E2 proteins to 
come within close proximity to enable ubiquitin transfer (Deshaies and Joazeiro 2009). 
 The first Cullin-RING Ligase family member to be reconstituted was that 
consisting of Cullin 1 (Cul1), Skp1 and the Fbox protein Cdc4, collectively referred to as 
an SCF complex. With the exception of Cul3 proteins, each cullin has a single adaptor to 
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which it binds. For Cul1, the adaptor protein is the s-phase kinase-associated protein 1 
(Skp1). Adaptor proteins bind cullins near the N-terminus, the opposite end of the 
scaffold from where the RING finger protein and the E2 bind (Deshaies and Joazeiro 
2009). Skp1 recognizes its binding partners through what is referred to as an F-box motif.  
 Although each cullin associates with a single adaptor, they have the capability to 
ubiquitinate hundreds of substrates each. This massive expansion in the repertoire of 
cullin substrates is due to the ability of each cullin adaptor to bind many substrate 
receptors. There are nearly 70 F-box containing proteins, which serve as the substrate 
receptors for Cul1 through their interaction with Skp1. Each of these F-box proteins 
contains substrate recognition domains, which have evolved to bind substrates with great 
specificity. The recognition motifs of the F-box domains vary greatly and, depending on 
the specific F-box protein, can recognize degrons comprising of phosphorylation, binding 
co-factors, glycosylation, small molecules and protein interactions accessible only when 
the target protein is not bound to its natural partner (Skaar, Pagan et al. 2013). Each 
substrate receptor can potentially bind multiple substrates provided that they contain 
similar degrons. Two exceptions should be noted: 1) Cul3 does not have a single adaptor 
protein and directly binds all of its substrate receptors (BTB domain proteins) (Deshaies 
and Joazeiro 2009) and 2) DDB2, a substrate receptor of Cul4, is known to bind damaged 
DNA and facilitate the ubiquitination of proteins in vicinity of the damage rather than the 
DNA itself (O'Connell and Harper 2007). 
 The F-box proteins can be subdivided into three broad categories based on 
additional domains that they possess. The first group is the Fbl proteins, which bind their 
substrates via a luecine rich repeat (LRR) domain. LRR domains tend to be shaped like a 
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scythe and known to be involved in protein binding. In this work, we will discuss Skp2, 
which is the best-studied Fbxl. Skp2 is special because it is known to function with an 
accessory protein, Cks1, which helps mediate binding to its substrates. The best studied 
of these substrates is the cell cycle inhibitor p27. p27 carries out its function by binding 
the heterodimer of a Cyclin-dependent Kinases (CDK) and its activating cyclin. p27 is 
thought to be a substrate of SCFSkp2 while it is bound to it to the cyclin-CDK dimer, 
although only p27 is ubiquitinated and destroyed (Skaar, Pagan et al. 2013).  
One particular target of p27 is cyclin E, or rather, the cyclin E-Cdk2 (EK2) 
heterodimer, which itself is a substrate of an SCF complex that contains the F-box protein 
Fbw7. Fbw7 belongs to the WD-containing class of Fbxw proteins. This class of proteins 
contains a WD domain, which forms a beta-propeller structure that serves as their 
substrate recognition domains. Many also contain D-domains allowing them to form 
homodimers. Some of the substrates for Fbw proteins, such as cyclin E, are known to 
have multiple degrons and it is thought that homodimerization of Fbw7 allows for more 
efficient ubiquitination of cyclin E and other target substrates by binding them in multiple 
locations (Welcker and Clurman 2008). It should be noted that since EK2 is part of two 
separate SCF complexes with each one degrading only a single protein, SCFSkp2 degrades 
p27 and SCFFbw7 degrades cyclin E, the implication of this finding is that the orientation 
of substrates can be a determining factor for which free lysine residues are covalently 
modified by ubiquitin.  
The third and final group of Fbox proteins is that of the Fbx “other”, or Fbxo, 
family. This category is more of a catch-all for non-LRR or non-WD-40 domain-
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containing F-box proteins, and some members of this class have very specific binding 
domains (Skaar, Pagan et al. 2013). 
Mutations in substrate receptors for every cullin have been linked to a number of 
diseases, particularly cancer. Those linked to cancer have been classified either as 
oncogenes or tumor suppressors. The full lists of these mutations have been widely 
published and specifics have been worked out for many of these proteins. For the 
purposes of our experiments, it should be noted that Skp2 is an oncogene and Fbw7 is a 
tumor suppressor. The mechanism of Skp2’s oncogenic activity appears to be by its 
overexpression leading to a reduction of its substrate p27. Since p27 is a cell cycle 
inhibitor, its reduction is thought to lead to an increase in cellular replication and a poor 
prognosis in cancer. Fbw7, on the other hand, is a major tumor suppressor, and when the 
substrate binding sites within its WD-40 domain are mutated there is a robust expression 
of its substrate, the well-known oncogenes, c-myc and Notch (Welcker and Clurman 
2008). 
Regulation by Cand1 
 For a long time it had been known that cullins bind numerous Fboxes that are all 
competing for the same binding site with fairly high affinity, since the entire SCF 
complex could survive being expressed in baculo cells, immunoprecipiated and purified 
by size-exclusion chromatography. It was also known that cullins could bind to a protein 
known as Cullin-associated Nedd8 dissociated 1 (Cand1). Cand1 was thought to play a 
role in sequestering cullins away from active ubiquitination by binding a large portion of 
the cullin near both termini. One of Cand1’s binding sites near the C-terminus of Cullins 
blocks the conjugation site of an activating modification by the Ubl Nedd8 discussed 
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below. Paradoxically, there has never been any clear evidence of Cand1 negatively 
regulating CRLs in vivo. In fact, as will become clearer with the data that has been 
recently published, as well as that which will be presented within this work, many 
“negative regulators” of the CRL pathway function to make the entire system quicker and 
more efficient (Lydeard, Schulman et al. 2013). 
 For the case of Cand1, it turns out that when a more complete set of CRL 
interactors are introduced to the system, its binding to Cullins is anything but static, and 
thus its proposed role as a sequestering agent is obsolete (Pierce, Lee et al. 2013). As it 
turns out, Fboxes and Cand1 can both bind to cullins with incredibly high affinity, as 
long as they are in isolation of one another. When the off-rate of the Fbw7-Skp1 complex 
from Cul1 was measured with and without the presence of Cand1, Cand1 was found to 
increase the rate by approximately one million-fold while having a mere two-fold effect 
the on-rate. The data very clearly showed that Cand1’s role in regards to SCFs was to act 
as an exchange factor, replacing substrate receptors and allowing the SCF to degrade a 
variety of substrates within a short period time. This showed that a protein which can 
both stably bind a Cullin, as well dissociate the CRL complex, can in fact help unbound 
substrate receptors gain access to the cullin. Moreover, it provided a rationale for why 
researchers were unable to find convincing evidence for Cand1 as a negative regulator of 
CRLs in vivo. 
Nedd8  
During the mid to late 90’s, people had discovered the gene for Nedd8. Although 
they did not quite understand its function, they knew that it was a Ubl and that it appeared 
in two forms, one as small monomeric Nedd8 as well as a second larger form which 
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migrated around 90 kDa (Kawakami, Chiba et al. 2001). Early biochemical studies 
revealed the E1, NAE1 (a heterodimer of Uba3 and APPBP1) and E2 (Ubc12) enzymes 
that are required for the neddylation of proteins. Interestingly, despite being the closest 
homolog of ubiquitin, Nedd8 was only found conjugated to proteins as a monomer. In 
fact, under normal physiological conditions one cannot readily see Nedd8 chains. Also, in 
the absence of over-expression, Nedd8 has only been found as a post-translation 
modification on Cullin family proteins. To this day, Cullins are the only validated targets 
of Nedd8 despite numerous reports of Nedd8 conjgation to other proteins. Later the Dcn 
family of E3 proteins (Defective in cullin neddylation) was found to facilitate the 
neddylation of cullins. In human cells these proteins appear to be partially redundant, and 
the exact function for each has not yet been differentiated (Lydeard, Schulman et al. 
2013). 
 Even today, the exact function of Nedd8 is not clearly understood. However, it 
has been known for a long time that Nedd8 acts as an activator of CRLs. Prior to the 
recent findings on the function of Cand1, it was thought to be a signal to inhibit Cand1’s 
function as a sequestering agent, thus allowing for more ubiquitination. Separately, 
Nedd8 has been shown to activate the transfer of ubiquitin by SCF in the absence of 
Cand1. Thus, Nedd8 provides at least two separate functions for the activation of cullins. 
Saha et al found that the modification of Nedd8 could activate almost every single aspect 
of E2 recruitment and ubiquitin transfer during the process of ubiquitination. Notebly, 
they found that Nedd8 enhances E2 recruitment to the SCF, brings the E2 in closer 
proximity to the substrate thus helping to bridge a 50 angstrom gap seen the crystal 
structures between substrate and E2, and increases the kcat of Ubiquitin transfer.  
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 Concurrent with the biochemical data that showed the effect of neddylation on the 
kinetic parameters of ubiquitination, the crystal structure of neddylated Cul5 was 
published. The crystal structure showed, in two asymmetric conformations, that the 
RING domain protein, Rbx1 in this case, did not have a large surface buried against the 
cullin as in the case of unneddylated Cul1. The attachment of Nedd8 appears to 
dramatically alter the C-terminus of cullins and allow the RING protein to pop up like a 
spring. This, along with the biochemical data, implied that one of the roles of Nedd8 is to 
alter the conformation of cullins to release its RING protein, which would allow the 
RING domain and its bound E2 to move closer to the substrate bound to the substrate 
receptors via the N-terminus of cullin. This can readily explain the shift in kinetic 
parameters seen upon neddylation.  
 It should be noted however that there is another explanation for the crystal 
structure and the effects of neddylation. Around this same time, there was an observation 
published by Singer and colleagues that Nedd8 allows for the dimerization of Cul3 in 
vivo . This model, albeit controversial, does have some precedence because other RING 
domains are known to function in dimers through their RING domains (Dou, Buetow et 
al. 2012). In the family of RBR proteins (RING in-between RING), two of the RING 
domains fold and bind one another (Koyano, Okatsu et al. 2014). However, Singer’s 
hypothesis was not thoroughly proven for two reasons: 1) the lysate assays were not done 
in the presence of neddylation or deneddylation inhibitors (the former was not first 
described until two years after this work was published) and 2) Many BTB proteins form 
homodimers similarly to Fboxes (Skaar, Pagan et al. 2013).  
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One striking effect that neddylation is now known to have is its ability to inhibit 
Cand1 mediated Fbox exchange. Through a series of powerful biochemical assays,  
Pierce et al. were able to show that neddylation can eliminate the ability of Cand1 to alter 
the off-rate of Fboxes. In essence, their data implied that when a cullin is bound to a 
substrate and neddylated, Cand1 could not perturb its ability to transfer ubiquitin 
molecules to its substrate (Pierce, Lee et al. 2013). 
Nedd8 is essential in almost all eukaryotes besides S. cerevisiae, which does not 
require its homolog, Rub1, under normal conditions. The role of cullins has been 
thoroughly noted in human diseases as described above, and there are currently 
neddylation inhibitors (MLN4924) being tested in clinical trials for the treatment of 
hematological tumors (Soucy, Smith et al. 2009). One association of the Nedd8 protein to 
human disease comes from a post-translation modification in Burkholderia pseudomallei 
and Enteropathogenic Escherichia coli (EPEC) by the protein cyclomodulin cycle 
inhibiting factor (CIF). CIF is known to deaminate both ubiquitin and Nedd8. The 
mechanistic specifics of the deamiation of Nedd8’s Gln40 to glutamate are still being 
worked out, but it appears that the alteration inhibits the activity of cullins and is directly 
responsible for some of pathogenesis found in EPEC infections (Morikawa, Kim et al. 
2010).  
Cop9 Signalosome (CSN) 
The first subunit of the Cop9 Signalosome, CSN, was discovered in Arabidopsis 
during the early 90’s when Deng and colleagues were screening for mutations that 
produced a constitutive photomorphogenic phenotype. A mutation in the Cop9 protein, 
which has since been named Csn8, was found to allow for photomorphogensis, the 
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response of seedlings in light, under both light and dark conditions. Thus the original 
phenotype of loss of function of the Cop9 Signalosome was the inability of seedlings to 
not sprout under dark conditions. Through some diligent work, it was discovered that 
CSN is 350 kDa, eight-subunit, heteromeric metalloprotease. To date, the only proven 
function of CSN is removal of Nedd8 from CRLs so as to return them to a state where 
they are less likely to engage in substrate ubiquitination and be more susceptible to Fbox 
exchange by Cand1. CSN shares considerable homology with both the lid complex of the 
19S regulatory cap of the proteasome as well as the translation initiation factor 3 (eIF3).  
All three of these complexes are made up of proteins that carry either a PCI domain 
(Proteasome, Cop9, Initiation Factor 3) or an MPN domain (Mpr1p and Pad1p N-
terminal). The MPN domains can be further subdivided into MPN+ or MPN- proteins 
depending on whether or not they contain a JAMM domain (Jab1/MPN Metalloprotease) 
capable of chelating the catalytic zinc ion. The JAMM domain proteins are a class of 
metalloenzyme, many of which play a role in ubiquitin or Ubl cleavage, such as the 
proteasome lid subunit Rpn11, the K63-linked DUB AMSH, as well BRCC36, the DUB 
in the BRCA1-RAP80 complex. Functionally, the JAMM domains chelate a zinc 
molecule using two histidines and an aspartate. The catalytic water molecule that is 
activated by a glutamate on a different loop offers the fourth chelation site for the zinc. 
CSN contains two MPN proteins as well as six PCI domain proteins. Of the two MPN 
domain proteins, Csn5 is the only active metalloprotease and carries out the only 
validated catalytic function of the Cop9 Signalosome. Csn5 catalyzes the removal of 
Nedd8 from cullin-RING ligases (Wei, Serino et al. 2008). The other MPN domain 
subunit, Csn6 does not have an active JAMM domain, but is thought to play a role in 
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regulating Csn5 activity (Lingaraju, Bunker et al. 2014). The remaining subunits all 
contain a PCI domain.  
 Recently, the crystal structure of CSN was published shedding a great deal of 
light onto its organization and potential regulation. The core of CSN is formed by two 
distinct organizational centers. The first is formed by the interdigitation of the winged-
helix domains (WH) of all eight subunits. A second organization center is formed on one 
side of the WH domains by the PCI domains of the six proteins that contain them. The 
remaining portions of the PCI domain subunits fan out into a horseshoe shape. On the 
opposite side of the WH domains rests the dimer of CSN5 and CSN6, which point toward 
the neddylated surface of the Cullin. The majority of the contact between the SCF and 
CSN appears to come from the N-terminus of Csn2 and potentially some from Csn4 
contacting the Rbx1 protein as well as Cul1. The data for Csn4 is implied by 
conformational shifts, but biochemical proof is still missing. N-terminal deletions 
mutants of Csn2, on the other hand have been show to be defective in deneddylating Cul1 
(Lingaraju, Bunker et al. 2014).  
JAMM domains share a large amount of homology, which is not surprising given 
that they all act on similar substrates. However they all contain one loop that is widely 
divergent. The Ins-1 loops of the different JAMM domains tend to be very different from 
each other, but are highly conserved among the same proteins in different species.  What 
is clear is that a large amount of specificity for substrates is derived from difference in 
Ins-1. In the case of Csn5, there appear to be four highly conserved residues that are all 
capable of hydrogen bonding, 103-TETR-106. As opposed to many other isopeptidases, 
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CSN appears to be autoinhibited and incapable of cleaving a model reagent consisting of 
a fluorophore attached to the C-terminus of ubiquitin or other UBLs.  Although CSN can 
readily cleave Nedd8 off of CRLs, another interesting fact is that CSN requires an intact 
complex to carry out its isopeptidase activity, i.e., Csn5 alone cannot cleave Nedd8 from 
Cul1. Recently, two papers have shed some light on the role of the Ins-1 in the 
autoinhibition of CSN. They have each made a single point mutant in either E104 or 
R106 that exhibit deregulated activity. In the case of the E104A mutation, the researchers 
were able to show that their CSN complex could cleave the fluorophore rhodamine from 
the C-terminus of ubiquitin. The results from the R106A mutation were less convincing, 
but implied that mutation of the arginine alleviates autoinhibition and this allows 
monomeric Csn5 to cleave Nedd8 from Cul1 (Echalier, Pan et al. 2013). More work is 
required to fully understand the functional role and regulation of CSN by Ins-1.  
As has been the case many times in the study of Cullin-RING- Ligases, the in 
vitro biochemical result that CSN inhibits CRL activity does not hold in the context of an 
intact cell. In fact, the result of either knocking down Csn5 in human cells or S. pombe 
was a stabilization of CRL substrates with a concomitant loss of Fboxes. Thus it appears 
that losing the negative regulatory function of CSN allows for ubiquitination by a CRL to 
run rampant and cannibalize its own substrate receptors. Originally, this was a rather 
confusing results but since the function of Cand1 has now been elucidated, it is clear that 
in the absence of neddylation, substrate receptors are incapable of being removed after 
the ubiquitination of their substrates and thus become targets of the E3 ligases 
themselves. This then can then potentially lead to the buildup of substrates in two distinct 
ways 1) new substrates will not be able to gain access to a cullin or 2) the rate of 
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degradation of substrate receptors will outstrip their rate of synthesis and thus the steady-
state levels of receptors will be insufficient to sustain recruitment and ubiquitination of 
CRL substrates. With almost every mechanistic insight that is discovered in the field of 
Cullin-RING Ligases, it appears that all of the players in the system are designed to make 
the system more efficient.  
A major focus of work in this thesis and in the future will be determining 
precisely how the timing of each piece of the system is controlled. The current theory for 
the regulation of deneddylation by CSN is that substrates inhibit deneddylation (Enchev, 
Scott et al. 2012). Unfortunately, this result has never been fully tested. A second major 
focus of this dissertation will be on the functional regulation of deneddylation of CRLs 
by CSN. The two primary mechanisms we sought to understand are what regulates the 
binding of CSN to its neddylated-CRL substrate and what role does Ins-1 play in 
regulating the isopeptidase activity of CSN.  
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Abstract 
 
COP9-Signalosome (CSN) mediates deconjugation of the ubiquitin-like protein Nedd8 
from the cullin subunits of SCF and other cullin–RING ubiquitin ligases (CRLs). This 
process is essential to maintain the proper activity of CRLs in cells. Here, we report a 
detailed kinetic characterization of CSN-mediated deconjugation of Nedd8 from SCF. 
CSN is an efficient enzyme, with a kcat of ~1 sec-1 and KM for neddylated Cul1–Rbx1 of 
~200 nM, yielding a kcat/KM near the anticipated diffusion-controlled limit. Assembly 
with an F-box–Skp1 complex markedly inhibited deneddylation, although the magnitude 
varied considerably, with Fbw7–Skp1 inhibiting by ~5-fold but Skp2–Cks1–Skp1 by 
only ~15%. Deneddylation of both SCFFbw7 and SCFSkp2-Cks1 was further inhibited ~2.5-
fold by the addition of substrate. Combined, the inhibition by Fbw7–Skp1 plus its 
substrate cyclin E was greater than 10-fold. Unexpectedly, our results also uncover 
significant product inhibition by deconjugated Cul1, which results from the ability of 
Cul1 to bind tightly to CSN. Reciprocally, CSN inhibits the ubiquitin ligase activity of 
deneddylated Cul1. We propose a model in which assembled CRL complexes engaged 
with substrate are normally refractory to deneddylation. Upon consumption of substrate 
and subsequent deneddylation, CSN can remain stably bound to the CRL and hold it in 
low state of reduced activity. 
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Introduction 
Cullin–RING ubiquitin ligases (CRLs) are heteromeric enzymes comprising cullin, 
RING domain, and substrate receptor subunits (Petroski and Deshaies 2005, Deshaies 
and Joazeiro 2009). The cullin subunit serves as the backbone of the enzyme, displaying 
on one end a substrate receptor complex that recruits substrates for ubiquitylation, and on 
the other end a RING domain subunit (Rbx1/Roc1/Hrt1) that recruits a ubiquitin-
conjugating enzyme that transfers ubiquitin to substrate.  
CRLs comprise a family of up to 240 enzymes that exert a profound effect on 
eukaryotic cells and organisms. CRLs, in aggregate, appear to account for ~20% of total 
protein degradation by the ubiquitin-proteasome system (UPS)(Soucy, Smith et al. 2009), 
and have been implicated in myriad processes that underlie normal development and 
physiology (Cardozo and Pagano 2004). CRLs and the pathways they control are also 
prominent targets of mutation in human diseases. For example, the most common genetic 
defect observed in colon cancer is of the APC pathway, which mediates degradation of b-
catenin via the CRL known as SCFb-TrCP (Frescas and Pagano 2008). Likewise, the CRL 
subunit Fbw7/Cdc4 is a prominent human tumor suppressor gene (Crusio, King et al.). 
Given their central roles in controlling numerous cellular processes, there is considerable 
impetus to understand how CRLs work and how they are regulated. Although much of 
the regulation in CRL pathways is focused on the substrates, the CRLs themselves are 
well-documented to be regulated by conjugation of the cullin subunit with the ubiquitin-
like protein, Nedd8 (Bosu and Kipreos 2008, Deshaies, Emberley et al. 2010).  
The Cop9 Signalosome is an 8-subunit complex that was originally discovered 
based on its role in controlling light-regulated development in Arabidopsis thaliana (Wei, 
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Serino et al. 2008). Insight into the molecular basis of CSN action began to emerge with 
the finding that in human cells CSN forms a stable complex with a particular subfamily 
of CRLs known as SCF ubiquitin ligases (Lyapina, Cope et al. 2001). A similar 
interaction was also detected in Arabidopsis (Schwechheimer, Serino et al. 2001). 
Importantly, CSN was shown to control Nedd8 modification of the Cul1 subunit of SCF 
(Lyapina, Cope et al. 2001). Whereas ~10-20% of Cul1 is typically modified with Nedd8 
in wild type Schizosaccharomyces pombe, in CSN-deficient cells the entire population of 
Cul1 is neddylated. The reason for this is that CSN-deficient cells lack an enzymatic 
activity that deconjugates Nedd8 from Cul1 (i.e. deneddylates). Subsequently, it was 
shown that this enzymatic activity resides within the Csn5 subunit of CSN and is 
specified by a novel metalloenzyme motif referred to as the ‘JAMM’ domain (Cope, Suh 
et al. 2002). It is now widely appreciated that CSN mediates deneddylation of all cullins, 
and appears to be the only enzyme capable of doing so with good efficiency (Bosu and 
Kipreos 2008, Deshaies, Emberley et al. 2010).  
In vitro, CSN inhibits CRL activity (Yang, Menon et al. 2002). This can be readily 
understood, because conjugation of Nedd8 to Cul1 stimulates the activity of SCF (Read, 
Brownell et al. 2000, Kawakami, Chiba et al. 2001, Duda, Borg et al. 2008, Saha and 
Deshaies 2008). But, multiple lines of genetic evidence indicate that CSN is required to 
sustain CRL activity in cells (Bosu and Kipreos 2008). This apparent paradox is resolved 
by the observation that CSN-mediated inactivation of CRLs counteracts autocatalytic 
breakdown of substrate receptor subunits (Wee, Geyer et al. 2005, Cope and Deshaies 
2006, Denti, Fernandez-Sanchez et al. 2006). Thus, the principal physiological function 
of CSN appears to be to sustain optimal levels of CRL activity. 
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Several lines of evidence point toward CSN playing an important role in human 
cancer, and potentially being a novel molecular target for cancer therapy. The catalytic 
subunit of CSN, Csn5, is overproduced in many human cancers, and its overproduction 
often correlates with poor survival (Shackleford and Claret 2010). Interestingly, the 
coding region for Csn5 is co-amplified along with that for c-Myc in some aggressive 
human breast cancers (Adler, Lin et al. 2006). Simultaneous overexpression of the two 
proteins synergistically activates c-Myc target genes, implicating Csn5 as a positive 
regulator of c-Myc. Moreover, expression of a catalytically-inactive mutant of Csn5 
greatly attenuates growth of a c-Myc-driven tumor in mice (Adler, Littlepage et al. 2008). 
Likewise, knockdown of Csn5 suppresses growth of hepatocellular carcinoma in mice 
(Lee, Judge et al.). Finally, four subunits of CSN were shown to be required for the 
growth of human colon cancer cells that express GTPase mutant K-Ras, but not of 
isogenic cells in which the oncogenic KRAS allele was deleted (Luo, Emanuele et al. 
2009). Taken together, these results suggest that CSN promotes cancer, and nominate 
Csn5 as a target for cancer therapy. 
To successfully target CSN in cancer will require a better understanding of how 
CSN works in cells, which in turn will require a better quantitative understanding of 
CSN’s biochemical properties. Although it has been known for ten years that CSN 
catalyzes the removal of Nedd8 from Cul1, the quantitative parameters for this reaction 
have yet to be described, due to the complexity of both the enzyme and its substrate. 
Here, we establish enzyme and substrate preparations and quantitative biochemical 
assays that allowed us to measure the steady-state kinetic parameters for substrate 
deneddylation by CSN. Our most important finding is that different F-box proteins can 
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directly inhibit deneddylation of their Cul1 partner to variable extents, and this inhibition 
is potentiated upon binding of substrate. We also find that CSN has unusually high 
affinity for its reaction product, unmodified Cul1–Rbx1. Finally, we document that CSN 
can also inhibit the ubiquitin ligase activity of purified, unmodified SCF, pointing to a 
new and unexpected role of CSN as a stoichiometric inhibitor of the activity of 
deneddylated CRLs. 
 
Results 
We set out to characterize in-depth CSN’s deneddylating activity by developing an 
in vitro assay in which the conversion of neddylated Cul1 to Cul1 could be quantitatively 
measured. CSN was purified from HEK293 cells that stably express the Csn2 subunit 
modified with an N-terminal FLAG tag (Wu, Yamoah et al. 2003). CSN recovered from 
an anti-FLAG affinity column was further enriched by gel filtration prior to being used 
for the experiments described here. All eight subunits were found to be present in the 
purified material, in apparently stoichiometric amounts (Fig. 1A). Mass spectrometry 
analysis of purified CSN identified two co-fractionating proteins (Ddb1 and Hsp70) that 
could not be totally removed by conventional methods such as high salt or treatment with 
ATP and Mg2+ (data not shown).  
To develop a quantitative, multi-turnover assay for deneddylation, we first sought 
to generate a labeled form of Nedd8. To this end, we fused a sequence encoding eight 
histidines followed by a protein kinase A phosphorylation site to the N-terminus of 
Nedd8 to generate His-PKA-Nedd8 (HPN8). When Cul1 was neddylated with HPN8 
(HPN8-Cul1) and subsequently purified by gel filtration and nickel-NTA 
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chromatography, the resulting CSN substrate was 98% neddylated as determined by 
SDS-PAGE (Supplemental Figs 1A, B). After radioisotope labeling with [32P]-ATP and 
cAMP-dependent protein kinase, >97% of the total signal from Nedd8 was attached to 
Cul1 as determined by phosphorimaging (Fig. 1B, time=0). When CSN (1 nM) was 
added to HPN8-Cul1 (50 nM) and the reaction progress analyzed, deneddylation 
proceeded at a linear rate (Fig. 1B, C).  
Prior to performing kinetic analyses, we carried out a series of control experiments. 
First we confirmed that the phosphorylated His-PKA tag had little to no effect on the rate 
of deneddylation of Cul1 (Supplemental Fig. 1C). Second, we compared rates of 
deneddylation by our FLAG-tagged CSN prepared from 293 cells with untagged CSN 
expressed in insect cells from recombinant baculoviruses (Supplemental Fig. 1D) and 
untagged CSN expressed in E. coli (Sharon, Mao et al. 2009) (Supplemental Fig. 1E). 
The FLAG tag had no discernable effect on the activity of CSN isolated from eukaryotic 
cells. Meanwhile, the enzyme purified from E. coli was ~2-fold less active, possibly due 
to removal of terminal sequences from some subunits to facilitate expression. 
To obtain enzymological metrics for CSN-mediated deneddylation, we evaluated 
reaction rate as a function of substrate concentration. CSN was held constant at 0.8 nM 
and the initial rates of deneddylation at varying concentrations of HPN8-Cul1–Rbx1 were 
determined (Supplemental Fig. 1F). The rates for each concentration of substrate were 
plotted and fitted to the Michaelis-Menten equation, which yielded a KM of 212 nM and 
kcat of 1.1sec-1  (Fig. 1D).  
Within cells, the fraction of Cul1 that is modified by Nedd8 is higher for Cul1 
bound to F-box proteins (Read, Brownell et al. 2000, Kawakami, Chiba et al. 2001, Chew 
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and Hagen 2007). We reasoned that this might arise from differential rates of 
deneddylation of Cul1, depending upon its assembly status. To test this possibility, we 
compared rates of deneddylation for HPN8-Cul1–Rbx1 versus three different HPN8-
conjugated SCF holoenzyme complexes. Deneddylation of HPN8-SCFFbw7 and HPN8-
SCFb-TrCP was assayed at 500 nM. Strikingly, Fbw7–Skp1 had a major effect, reducing 
the rate of deneddylation by 5.8-fold (Fig. 2A). b-TrCP–Skp1 had a weaker effect, 
reducing the rate by 2.2-fold. However, the recombinant b-TrCP used for this experiment 
lacks the N-terminal 138 amino acids, which were removed to facilitate efficient 
expression (Wu, Xu et al. 2003). Interestingly, not all F-box proteins were inhibitory. 
Addition of Skp2–Cks1–Skp1 reduced the rate of deneddylation by <20% (Fig. 2B). We 
do not understand the basis for this difference in behavior but note that endogenous Cul1 
co-precipitated with transiently expressed F-box proteins was ≥50% neddylated in b-
TrCP and Fbw7 immunoprecipitates, but considerably less modified in Skp2 
immunoprecipitates (Supplemental Fig. 2A, B and data not shown).  
In other work we have shown that a mutant of Skp1 (Skp1∆∆) used for 
crystallography (Schulman, Carrano et al. 2000) that lacks two acidic internal loops was 
able to bind Cul1–Rbx1 and assemble an active SCF complex, but was unable to promote 
displacement of Cand1 from Cul1–Rbx1 (Goldenberg, Cascio et al. 2004) (N. Pierce and 
R.J.D., unpublished data).  Because Fbw7–Skp1 had the most potent effect on 
deneddylation, we tested the impact of the Skp1 loops in this context. Interestingly, the 
loop deletions reduced the inhibitory effect of Fbw7–Skp1 by ~2.5-fold (Supplemental 
Fig. 3). However, the acidic loops of Skp1 were not sufficient to specify inhibition of 
deneddylation, because our Skp2–Cks1–Skp1 contained wild type Skp1. 
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Given the substantial effect of Fbw7–Skp1 on deneddylation, we next sought to test 
whether binding of substrate to Fbw7 might further influence deneddylation of the 
associated HPN8-Cul1. There is good reason to think this might be the case – Cul1 co-
precipitated from cells with SCF substrates is essentially 100% neddylated (e.g., see 
(Read, Brownell et al. 2000)), implying that substrate might either increase the rate of 
neddylation or decrease the rate of deneddylation above and beyond the effect of the F-
box protein. Consistent with this possibility, the addition of the Skp2–Cks1 substrate 
p27kip1 to SCFSkp2-Cks1 complexes in fractionated cell lysate decreases Cul1 deneddylation 
(Bornstein, Bloom et al. 2003). However, because this experiment was carried out with 
undefined protein fractions, a clear explanation for this phenomenon remains lacking.  
To test the effect of substrate in a defined system, we compared the rate of 
deneddylation of HPN8-SCFFbw7 in the presence and absence of full-length phospho-
cyclin E bound to Cdk2. Cyclin E must be phosphorylated on at least two sites (T380 and 
S384) to serve as a substrate for SCFFbw7 (Welcker, Singer et al. 2003). Addition of 
phospho-cyclin E–Cdk2 further reduced the rate of deneddylation of HPN8-SCFFbw7 by 
~2.5-fold (Fig. 2C). The effect of substrate was specific, because phospho-cyclin E–Cdk2 
had no effect on the rate of deneddylation of HPN8-Cul1 in the absence of Fbw7–Skp1 
(Fig. 2D). Together, Fbw7 plus phospho-cyclin E reduced deneddylation by >10-fold. 
Note that this experiment was done with 50 nM substrate, in contrast to Fig. 2A which 
was done with 500 nM. Thus, the inhibitory effect of Fbw7–Skp1 on deneddylation of 
HPN8-Cul1 was similar when CSN was either sub-saturated or nearly saturated with 
substrate. To determine whether the effect of substrate applies to other SCF complexes, 
we tested the effect of phospho-p27–cyclin E–Cdk2 substrate on HPN8-SCFSkp2–Cks1. 
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Addition of substrate reduced the rate of deneddylation by ~2.3-fold (Fig. 2B), similar to 
what was seen in Fig. 2C. A similar magnitude of substrate-mediated inhibition was 
observed when SCFSkp2 complexes were assayed in the presence of phospho-p27–cyclin 
E–Cdk2 under conditions that were permissive (+Cks1) or not permissive (-Cks1) for 
substrate binding and ubiquitylation (Fig. 2E). Taken together, these results imply that 
substrate reduced the rate of deneddylation equivalently regardless of whether or not it 
was undergoing ubiquitylation. 
Cullin deneddylation in vivo must occur in the presence of a substantial 
concentration of unmodified cullins as well as a large constellation of factors that bind 
cullins, any one of which might have an impact on the rate of deneddylation. To address 
this issue, we evaluated deneddylation of HPN8-Cul1–Rbx1 in the presence of different 
recombinant proteins purified from E. coli and added at a fixed concentration of 1 µM. 
Neddylated substrate was mixed with each potential regulator and allowed to interact for 
5 minutes at room temperature before CSN was added and the reaction progress was 
monitored. Interestingly, every single factor that was tested reduced the rate of 
deconjugation of HPN8 from substrate. The factors tested fell into two categories based 
on their ability to repress CSN deneddylase activity: moderate inhibitors (Ubc12, Dcn1, 
UbcH5C, Nedd8) which repressed deneddylation by 2.2 to 4.8 fold, and strong inhibitors 
(Cul1, Ubxd7, Cdc34, Cand1) which repressed deneddylation between 7.2 and 14.4 fold 
(Fig 3A). Supplemental Table 2 contains initial rates of deneddylation in the presence of 
each factor tested. Based on these results, we pursued in more detail the inhibition of 
deneddylation by Cand1 and unmodified Cul1–Rbx1.  
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Cand1 was previously reported to interact exclusively with unmodified cullins, 
including Cul1–Rbx1 (Liu, Furukawa et al. 2002, Zheng, Yang et al. 2002). Consistent 
with this, the co-crystal structure of Cul1–Rbx1–Cand1 showed that the Nedd8 
conjugation site of Cul1 is partially obscured by Cand1 (Goldenberg, Cascio et al. 2004). 
Moreover, the crystal structure of Nedd8 conjugated to the C-terminal domain of Cul5 
showed how a Nedd8-induced conformational change blocks binding of the N-terminal 
domain of Cand1 (Duda, Borg et al. 2008). Therefore, we were surprised to find Cand1 
was a potent inhibitor of deneddylation (Fig. 3A). We investigated this property further in 
our in vitro deneddylation assay by keeping the concentrations of HPN8-Cul1–Rbx1 
substrate (150 nM) and CSN enzyme (0.8 nM) constant and varying the concentration of 
Cand1. This experiment yielded an apparent inhibition constant of 160 nM (Fig. 3B). 
Two lines of evidence suggest that Cand1 inhibited deneddylation by binding substrate: 
addition of Cand1 increased the KM but did not affect the kcat for deneddylation of HPN8-
Cul1 (Fig. 3C), and Cand1 exhibited no effect on the initial rate of deneddylation of 
HPN8-SCFSkp2–Cks1 (Fig. 3D). These data suggest that binding of the C-terminal domain 
of Cand1 to the N-terminal domain of Cul1 (which is blocked by Skp1–Skp2–Cks1) 
interferes with recruitment of CSN. Notably, in Aspergillus, Cand1 is naturally split into 
two polypeptides, and the polypeptide corresponding to the C-terminal portion of human 
Cand1 can bind Cul1 in the absence of the N-terminal portion (Helmstaedt, Schwier et al. 
2011). 
CSN was also strongly inhibited by its reaction product, unmodified Cul1–Rbx1 
(Fig. 3A). We determined the IC50 for Cul1to be 260 nM when assayed at 50 nM 
substrate (Fig. 3E) This suggests that the Nedd8 modification must not confer a large 
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amount of affinity for CSN, which is consistent with our observation that free Nedd8 was 
a weak inhibitor of deneddylation (Fig. 3A). The surprisingly strong apparent affinity of 
unmodified Cul1–Rbx1 product for CSN is consistent with our original discovery that 
CSN associates with a mutant Cul1 that lacks the extreme C-terminus including the 
Nedd8 conjugation site (Lyapina, Cope et al. 2001), and raises the possibility that product 
dissociation might be rate-limiting for substrate deneddylation. 
To conclusively demonstrate that CSN can form a stable interaction with 
unmodified SCF, we mixed purified CSN with purified SCFSkp2–Cks1 and fractionated the 
mixture on a Superdex 200 size exclusion column. SCFSkp2–Cks1 that was not mixed with 
CSN was used for comparison purposes. In the presence of CSN, a fraction of the 
SCFSkp2–Cks1 molecules were shifted to higher molecular weight fractions, corresponding 
to fractions that contained CSN (Fig. 4A).  
To test whether unmodified full-length Cul1 (i.e. the product of deneddylation) 
exhibits significant binding to CSN in cells, we transiently transfected HA epitope-tagged 
wild type and K720R Cul1 expression constructs into HEK293 cells. K720R lacks the 
site on Cul1 to which Nedd8 is conjugated. Twenty-four hours post transfection, cells 
were lysed and the HACul1 was immunoprecipitated with HA antibody. The 
immunoprecipitates were then immunoblotted with antibodies to detect HACul1 as well as 
the endogenous Skp1, Rbx1, Csn5 and Cand1 proteins (Fig. 4B). Whereas wild type and 
K720R HACul1 were expressed at similar levels and bound similar amounts of Rbx1 and 
Skp1, the K720R mutant actually retrieved more Csn5 than wild type. By comparison, a 
recent proteomic study reported equivalent association of CSN with wild type and 
K720R-Cul1 in HEK293T cells (Bennett, Rush et al.). As independent confirmation of 
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this result, we examined the interaction of endogenous Cul1 with transiently-expressed 
FLAG-tagged Csn5. Cul1 co-immunoprecipitated with FLAGCsn5 was exclusively in the 
unconjugated form (Fig. 4C). Even if deconjugation occurred within the CSN–SCF 
complex in vitro, this result emphasizes the point that unlike traditional enzymes, CSN 
did not rapidly let go of its substrate upon deconjugating it. To more directly compare the 
association of CSN with neddylated and unmodified Cul1, we repeated this experiment 
with FLAGCsn5-ASA, which is mutated for two of the histidine residues that play a critical 
role in forming the active site that mediates deneddylation (Cope, Suh et al. 2002, 
Ambroggio, Rees et al. 2004). Although most of the endogenous Cul1 that co-
immunoprecipitated with FLAGCsn5-ASA was modified with Nedd8, a substantial pool of 
unmodified Cul1 was recovered, confirming that unmodified cullin substrate can 
associate stably with CSN. Finally, to explore structure-activity relationships in greater 
depth, we also evaluated binding of endogenous CSN to HACul1 variants that could not 
bind to Skp1 and Rbx1. These mutants were generated by using the X-ray crystal 
structure of SCF as a guide (Zheng, Schulman et al. 2002). Both of these mutants bound 
less Csn5 (Fig. 4 B). The failure of the RING-deficient mutant to bind CSN is consistent 
with the original finding that Csn2 binds Rbx1 in a yeast 2-hybrid assay (Lyapina, Cope 
et al. 2001). Taken together, our data suggest that CSN exhibits a complex mode of 
interaction with Cul1 that is not dependent on Nedd8 and involves both ends of the 
elongated CRL complex. 
Stable binding to substrate and/or product is unusual for an enzyme and suggested 
to us that CSN might regulate CRLs by mechanisms other than deconjugation of Nedd8. 
This possibility is further supported by our observation that multiple factors that interact 
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with Cul1, including the E2 enzymes UbcH5C and Cdc34, inhibited deneddylation of 
HPN8-Cul1–Rbx1. We therefore set out to test if CSN can inhibit SCF activity, 
independently of its effects on Nedd8 conjugation. An ubiquitylation reaction was set up 
that contained unmodified SCFβTrCP plus radiolabelled β-catenin peptide, ubiquitin, E1 
and either UbcH5C or Cdc34. The ubiquitylation reaction was initiated by the addition of 
ATP and Mg2+ followed by the addition or omission of 300 nM CSN (which is slightly 
less than the estimated in vivo concentration of 500 nM in 293 cells; (Bennett, Rush et al. 
2010)). The addition of CSN resulted in a 3.4 – 3.8-fold reduction in the rate of substrate 
conversion to products, independent of the E2 that was employed (Figs 5A, B). Inclusion 
of CSN affected both the extent of substrate conversion as well as the pattern of reaction 
products that were produced, indicating that CSN affected both ubiquitin chain initiation 
and elongation. 
UbcH5 and Cdc34 catalyze SCF-dependent substrate ubiquitylation with KM values 
that differ by about an order of magnitude (Saha and Deshaies 2008). Their equivalent 
sensitivity to inhibition by CSN suggested that CSN might not compete with E2 for 
binding to unmodified SCF. Consistent with this, 300 nM CSN exerted a similar fold 
inhibition of ubiquitylation in reactions that contained either 1 µM or 10 µM Cdc34 
(Supplemental Fig. 4A). We also evaluated whether CSN might compete with substrate. 
Regardless of whether cyclin E peptide substrate was present at 0.1 µM or 1 µM, 300 nM 
CSN inhibited SCFFbw7 to a similar degree (Supplemental Figure 4B). 
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Discussion 
CSN mediates deneddylation of all cullins in vivo. However, the quantitative 
kinetic parameters of CSN-mediated deneddylation have remained largely unknown, 
owing in part to the complexity of the enzyme and its substrate. In this work, we 
developed reagents and methods that enabled us to measure quantitatively the 
deconjugation of radiolabeled Nedd8 from a purified Nedd8-Cul1–Rbx1 substrate. Here, 
we consider the implications of our quantitative measurements for the physiological 
function of CSN. 
Affinity of CSN for substrate and product: Our studies reveal that CSN has high 
affinity (KM = 212 nM) for Cul1 substrate. We do not know the KD for the interaction, but 
given that kcat/KM is in the diffusion-limited range, it is possible that KD is considerably 
lower than KM.  Contrary to what has been suggested elsewhere (Choo, Boh et al. 2011), 
we also show that deneddylated cullin binds tightly with CSN, although not quite as 
tightly as neddylated substrate. At least 4 lines of evidence support this claim: (1) CSN 
activity was significantly inhibited by unmodified Cul1–Rbx1, with an IC50 of 260 nM 
(Fig. 3E); (2) unmodified SCFSkp2–Cks1 was shifted to higher molecular weight fractions 
on Sephadex 200 in the presence of CSN (Fig. 4A); (3) Csn5 stably co-precipitated with a 
mutant of Cul1 that cannot be neddylated (Fig. 4B); and (4) deneddylated Cul1 co-
precipitated with both wild type Csn5 and a mutant that lacks deneddylase activity (Fig. 
4C). These data add to a considerable body of evidence that CSN binds tightly to its 
reaction product. Indeed, the role of CSN in CRL biology was first discovered based on 
its efficient co-immunoprecipitation with a C-terminal truncation mutant of Cul1 that 
lacks the lysine 720 that Nedd8 is conjugated to (Lyapina, Cope et al. 2001). In the recent 
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quantitative proteomic study of Bennett et al, they reported that even in the absence of 
Nedd8 conjugation (brought about by the addition of the Nedd8 conjugation inhibitor 
MLN4924 to cells), nearly 50% of Csn6 remains associated with cullins 1 through 5 
(Bennett, Rush et al. 2010).  
Given the surprisingly tight binding of unmodified Cul1 to CSN and the total 
relative concentrations of CSN (500 nM) and Cul1-Cul5 (~1250 nM) in cells (Bennett, 
Rush et al. 2010), of which we estimate based on data shown in (39) that ~35% (~450 
nM) is neddylated, it is plausible that the entire cellular pool of CSN is essentially 
saturated with neddylated and unmodified cullins. Indeed, based on the mole fraction of 
Csn6 that is bound to individual cullins, up to 60% of CSN remains associated with 
cullins following immunoprecipitation (Bennett, Rush et al. 2010). It is a reasonable 
possibility that most of the remaining 40% of CSN was also bound to cullins in cells but 
dissociated during the preparation and washing of the immunoprecipitates. Thus, it is 
possible that in cells, dissociation of CSN from CRLs is rate-limiting for deneddylation. 
Catalytic rate of CSN: At saturating concentrations of Nedd8-modified Cul1 
substrate, the maximal rate of CSN-mediated deneddylation is ~1 sec-1, Although 
reasonably fast, this kcat is ~100-fold slower than the maximal rate of cleavage of the 
model substrate CbzGly-L-Phe by the zinc metalloprotease carboxypeptidase A 
(Spilburg, Bethune et al. 1977).  What is puzzling about the multi-turnover rate of 1 sec-1 
is that it implies that the rate of product dissociation must be at least this fast. However, 
this is difficult to reconcile with the observations noted in the prior section that CSN 
binds to deneddylated CRLs with sufficient stability to survive gel filtration or 
immunoprecipitation. Resolution of this conundrum will require further experimentation. 
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A notable feature of the neddylation cycle is the rate at which it proceeds in cells. 
Application of the Nedd8 conjugation inhibitor MLN4924 to cells results in rapid loss of 
Nedd8 conjugates; although quantification was not reported, a conservative estimate is 
that 80% of neddylated cullins are consumed within 5 minutes (Soucy, Smith et al. 2009). 
This represents a minimal rate for deneddylation, since earlier time-points were not 
evaluated and it takes a finite amount of time for the drug to penetrate cells and effect 
depletion of the pre-existing pool of Ubc12~Nedd8 thioesters. Regardless, this rate is 
easily achievable. At the estimated cellular concentrations of CSN and total Nedd8-
conjugated cullins (500 nM and 450 nM, respectively) and the kcat/KM for deneddylation 
reported here (~5 x 106 M-1 sec-1), the pool of cullins could be extensively deneddylated 
within several seconds upon extinguishing Nedd8 conjugation activity. 
Inhibition of deneddylation by F-box proteins, substrates, and other Cul1-binding 
factors:  A key finding of this manuscript is that binding of F-box–Skp1 complexes to 
Cul1 can substantially reduce the rate of deneddylation. Fbw7–Skp1 slowed 
deneddylation by ~5-fold, and this effect was increased to >10-fold upon addition of 
phospho-cyclin E–Cdk2 substrate. Thus, in the environment of the cell where CSN is 
essentially saturated with neddylated and unmodified cullins, fully assembled SCF 
complexes that are engaged with substrate are expected to be comparatively immune to 
the action of CSN. This has important implications for the regulation of SCF complex 
deactivation and disassembly. Accumulation of substrate for a particular CRL complex 
would be expected to lead to accumulation of the Nedd8-conjugated form of that 
complex (Fig. 6, step 1). Upon consumption of the substrate (step 2), the CRL complex 
would either be subject to autoubiquitylation and degradation of the substrate receptor 
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(step 5) or recruit CSN and be deneddylated (step 3). Reappearance of substrate would 
lead to displacement of CSN (step 4) and re-formation of neddylated, active complex 
(step 1). By this mechanism, CRL complexes for which substrate is present would be 
preferentially neddylated and activated. In the absence of CSN (gray zone) this regulation 
would be undermined, and upon depletion of substrate for a particular CRL, the complex 
would remain conjugated to Nedd8 and active (step 2), leading to autoubiquitylation and 
ultimately degradation of the substrate receptor and inactivation of the CRL (step 5). We 
speculate that substrate adaptors that are most prone to become ubiquitinated in the 
absence of bound substrate will be the most sensitive to loss of CSN function. Several 
important questions remain unanswered by this model. For example, how do F-box 
proteins and substrates inhibit deneddylation? Why does Fbw7–Skp1 but not Skp2–
Cks1–Skp1 potently inhibit deneddylation? How does Cand1 fit into this cycle? 
In addition to Fbw7–Skp1, which interacts with the N-terminal domain of Cul1, 
every factor that is known to contact Rbx1 and/or the C-terminal domain of Cul1 that was 
tested here (UbcH5c, Cdc34, Ubc12, Dcn1, Ubxd7, Cand1) also inhibits deneddylation of 
Cul1 by CSN to some extent. We conclude that CSN is likely to make extensive contacts 
with Rbx1 and the C-terminal domain of Cul1. Our observation that Cand1 inhibits 
deneddylation is in direct conflict with a report to the contrary (Min, Kwon et al. 2005). 
We do not understand the reason for the discrepancy, but note that those authors 
measured deneddylation in a buffer that is completely lacking salt. We also draw 
attention to the inhibition of deneddylation by Ubxd7. Ubxd7 binds directly to the Nedd8 
modification via an internal UIM domain (Bandau, Knebel et al. 2012, Besten, Verma et 
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al. 2012). Overexpression of Ubxd7 can cause accumulation of Nedd8-conjugated Cul2, 
suggesting that it can shield Cul2 from CSN in vivo. 
CSN inhibits CRL activity by catalytic and non-catalytic mechanisms: CSN 
initiates deactivation of a neddylated CRL complex by reversing the Nedd8 modification. 
The deconjugated CRL has several fold less ubiquitin ligase activity (Read, Brownell et 
al. 2000, Kawakami, Chiba et al. 2001, Duda, Borg et al. 2008, Saha and Deshaies 2008). 
We suggest that in some instances, CSN remains stably bound to its product, and this 
reduces ubiquitin ligase activity even further. To investigate this possibility, we evaluated 
the effect of CSN on the basal activity of SCF that was not neddylated. Remarkably, 300 
nM CSN (which is lower than its intracellular concentration) inhibited unmodified SCF 
by up to 3.5-fold. Equivalent inhibition of unmodified SCF occurred regardless of 
whether Cdc34 or UbcH5 was used as the E2, or whether Cdc34 was added at 0.1 (not 
shown), 1, or 10 µM. These observations suggest that the non-catalytic inhibitory activity 
of CSN was not competitive with respect to E2, even though E2 was able to inhibit 
deneddylation of HPN8-Cul1 by CSN. Likewise, CSN exhibited equivalent inhibition of 
SCFFbw7when assays were conducted with 0.1 or 1 µM cyclin E peptide substrate. We 
suggest that the E3 inhibition is a kcat effect that arises because CSN restrains SCF in a 
low-activity conformation. Regardless of the exact mechanism, non-catalytic regulation 
is likely to be physiologically relevant, because nearly 30% of Cul1 and >40% of Cul4B 
are stably bound to CSN in 293T cells (Bennett, Rush et al. 2010). Indeed, genetic studies 
implicated fission yeast Csn1 and Csn2, but not Csn5, as being required for a specific 
function of CRL4 (Holmberg, Fleck et al. 2005), and a recent publication reported that 
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expression of catalytically inactive Csn5 partially restores proper CRL regulation in a 
Neurospora mutant that lacks Csn5 (Zhou, Wang et al. 2012).  
While this manuscript was being drafted, it was reported that CSN potently inhibits 
autoubiquitylation of substrate receptor subunits within CRL4ADDB2 and CRL4ACSA 
complexes (Fischer, Scrima et al. 2011). Remarkably, this inhibition was relieved by 
addition of a ligand for the substrate receptor. This suggests that binding of 
ligand/substrate to CSN–CRL4A complex activates CRL4A by facilitating dissociation 
of CSN. Interestingly, CRL4ACSA efficiently polyubiquitinates its substrate CSB in the 
presence of CSN. Although this is in apparent conflict with our results, the kinetics of 
CSB ubiquitylation were not evaluated in the presence and absence of CSN, so it is 
possible that CSN retards ubiquitylation of CRL4A substrates much as it does for SCF as 
shown here. 
Improvements in biochemical assay methods (Saha and Deshaies 2008, Kleiger, 
Hao et al. 2009, Kleiger, Saha et al. 2009, Pierce, Kleiger et al. 2009) and mass 
spectrometry-based quantification (Bennett, Rush et al. 2010, Lee, Sweredoski et al. 
2011) have begun to give us a much clearer picture of the numerical parameters that 
govern the ubiquitin ligase activity of CRLs and the mechanisms that regulate this 
activity. Systematic pursuit of these approaches, coupled with structural biology and 
enzymology, promises to reveal a detailed picture of how these enzymes work, how their 
activities are controlled, and how these features relate to their physiological roles in cells. 
We propose that this information will enable researchers to make good on the promise of 
basic science by developing novel medicines that target CRLs. Already, encouraging 
steps have been made in that direction (Ceccarelli, Tang et al. , Orlicky, Tang et al. , 
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Soucy, Smith et al. 2009, Aghajan, Jonai et al.), and we can only hope, for the sake of 
patients, that there will be more to follow. 
 
Materials and Methods 
Purification of CSN 
293F23V5 cells (gift from ZQ Pan, Mount Sinai School of Medicine, New York) stably 
expressing FLAG-Csn2 and Csn3-V5 (DTC# 56) were adapted to grow under suspension 
conditions in FreeStyle 293 Expression Medium (Invitrogen). When an approximate cell 
density of 5x105 cells/mL was reached in a culture volume of 500 mL, cells were 
pelleted, washed once in cold PBS, pelleted again and flash frozen in liquid N2. CSN was 
affinity purified using anti-FLAG M2 resin (Sigma) as previously described (Yamoah, 
Wu et al. 2005), except binding occurred over a 2 hour period, 1 mM EDTA was used, 
EGTA was omitted and Complete Mini EDTA-free Protease Inhibitor Cocktail (Roche) 
was used instead of individually adding different inhibitors. Following affinity 
purification, CSN was concentrated and immediately loaded onto a Superdex-200 gel 
filtration column equilibrated with 25 mM Tris, pH 7.5, 100 mM NaCl, 1 mM 
dithiothreitol, and 10% glycerol (storage buffer). Fractions containing CSN were pooled, 
concentrated with an Amicon Ultra-4 30k MWCO (Millipore), and aliquoted for storage 
at -80°C.  
Purification of Nedd8  
The artificial gene His8-PKA-Nedd8 was designed to aid in the purification of in vitro 
neddylated Cul1 and to be radiolabeled with 32P for quantitative enzymatic analysis. The 
gene encoding the amino acid sequence 
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MHHHHHHHHRRGSLMLIKVKTLTGKEIEIDIEPTDKVERIKERVEEKEGIPPQQQR
LIYSGKQMNDEKTAADYKILGGSVLHLVLALRGG, was purchased from DNA2.0 
and put into their expression plasmid pJexpress414 (RDB# 2673). Expression was in 
BL21 (DE3) bacterial cells under ampicillin selection. 1 L cultures were grown at 37oC 
until an OD600 of ~1.0 was reached. The temperature was dropped to 16°C before 
addition of isopropyl β-D-1-thiogalactopyranoside. Induction was carried out at 16°C 
overnight. Bacterial pellets were lysed by sonication in a buffer containing 50 mM Tris-
HCl pH 7.6, 100 mM NaCl, 2 mM dithiothreitol and Complete Mini EDTA-free Protease 
Inhibitor Cocktail (Roche).  The lysates were clarified by centrifugation and incubated 
with 1.5 mL of Ni Beads (Qiagen) per pellet from a 1 L culture. Binding to resin was 
allowed to occur for 2 h at 4oC. The resin was washed two times with 50 column volumes 
of lysis buffer, followed by elution with 25 mM Tris, pH 7.5, 100 mM NaCl, and 200 
mM imidazole. This mixture was then loaded onto a Superdex-75 gel filtration column 
equilibrated in storage buffer composed of 25 mM Tris, pH 7.5, 100 mM NaCl, 1 mM 
dithiothreitol, and 10% glycerol.  Fractions with His8-PKA-Nedd8 were concentrated, 
and the purified protein was frozen at -80°C.  
Expression and Purification of Recombinant Proteins 
All proteins as outlined in Table S3, were expressed in either E. coli or Hi5 insect cells 
and purified using standard procedures. Ubxd7 was a gift from W. den Besten. Dcn1 was 
a gift from B. Schulman (St. Jude, Memphis). CSN expressed and purified from E. coli 
was a gift from N. Zheng (University of Washington, Seattle). Phosphorylated Cyclin E–
Cdk2 was a gift from B. Larimore (Clurman laboratory, University of Washington, 
Seattle). 
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In Vitro Neddylation Reaction 
Cul1–Rbx1 was neddylated with His8-PKA-Nedd8 (HPN8) using conditions previously 
described (Duda, Borg et al. 2008), with the exception that His8-PKA-Nedd8 was used at 
a concentration of 40 µM. Cul1–Rbx1 conjugated with HPN8 was purified by standard 
column chromatography techniques, using first S-sepharose, followed by binding to Ni-
affinity matrix and then Superdex-200 gel filtration. For the experiments shown in 
Supplemental Figs. 1C and D, neddylation reactions were terminated by addition of 5 µM 
MLN4924 and then diluted directly into a deneddylation reaction. 
In Vitro Deneddylation Reaction 
Deneddylation reactions in Figs. 2E and 3 were carried out with 0.8 nM CSN in a 1X 
deneddylation buffer containing 25 mM Tris, pH 7.5, 100 mM NaCl, 1 mM dithiothreitol, 
5% glycerol and 1ng/µl ovalbumin. Deneddylation reactions in Fig. 2A and Supplemental 
Figs. 1C, 1D and 3 were carried out with 1 nM CSN in deneddylation buffer containing 
25 mM Tris pH7.5, 100 mM NaCl, 1 mM DTT, 1% glycerol, 1 ng/µl ovalbumin. 
Deneddylation reactions in Fig. 2B, C, and D were carried out with 1 nM CSN in 
deneddylation buffer containing 25 mM Tris pH7.5, 50 mM NaCl, 1 mM DTT, 1% 
glycerol, 15 ng/µl ovalbumin 25 mM trehalose. See figure legends for the time of 
reaction and the concentrations of the reaction components. All reactions were performed 
at room temperature (23-25oC). Deneddylation reactions were quenched with reducing 
SDS-PAGE buffer and separated by SDS-PAGE on 16% gels. The gels were dried and 
exposed to a phosphor screen for analysis. Quantification was performed with 
ImageQuant (GE Healthcare) and plotted using GraphPad Prism. All values reported are 
the average of at least two independent experiments. Rates of deneddylation were 
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calculated by dividing the signal for free [32P]-labeled HPN8 by the summed signals for 
[32P]-labeled HPN8–Cul1 and free HPN8 to obtain % deneddylation. The amount of free 
Nedd8 formed was then calculated as: (% deneddylation) * (concentration of input 
HPN8-Cul1–Rbx1)/100. For the experiments shown in Figs. 2A-D, initial rates were 
calculated excluding the first 10 seconds, due to the apparent biphasic nature of some of 
the reactions, which we ascribe to a small fraction of Cul1 that did not assemble with F-
box–Skp1 or substrate, and was therefore deneddylated more rapidly. 
Ubiquitylation Reaction 
All of the ubiquitylation reactions were carried out as previously described (Saha and 
Deshaies 2008) in a reaction buffer composed of 25 mM Tris, pH 7.5, 100 mM NaCl, 5 
mM MgCl2, 2 mM ATP, 1 mM dithiothreitol. All reactions were performed at room 
temperature (23oC). See figure legends for the time of reaction and the concentrations of 
the reaction components. Ubiquitylation reactions were quenched with reducing SDS-
PAGE buffer and separated on 16% Tris-glycine SDS-PAGE gels. The gels were dried 
and exposed to a phosphor screen for analysis. Quantification was performed with 
ImageQuant (GE Healthcare) and plotted using GraphPad Prism. All values reported are 
the average of at least two independent experiments, except Supplemental Fig 4. 
Cell culture, Immunoprecipitation and Western Blot 
HEK293T cells were obtained from A.T.C.C. and grown under standard cell culture 
conditions in DMEM supplemented with 10% FBS. For transfection, Lipofectamine2000 
was used according to the manufacturer’s instructions (Invitrogen). A description of the 
plasmids used in this study for transfection and immunoprecipitation is provided in Table 
S2. Twenty-four hours post transfection, cells were rinsed in cold phosphate-buffered 
	   46	  
saline and lysed in 400 µM cold lysis buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1 
mM EGTA, 0.1% NP-40, Complete Mini EDTA-free Protease Inhibitor Cocktail 
(Roche)). Lysates were cleared by centrifugation at 12,000 X g for 10 minutes at 4oC, 
followed by incubation with either anti-HA (Covance), anti-M2 FLAG (Sigma), or anti-
myc (Covance) and 30 µl Tris-Acryl protein A (Pierce) at 4oC for 2 hours with rotation. 
Resins were washed four times with lysis buffer and resuspended in SDS sample buffer. 
Proteins bound to resin were resolved by SDS-PAGE on a 7, 10 or 12.5% gel. 
Immunodetection was performed with antisera to Cul1 and Skp1 (Invitrogen), Cand1 
(Calbiochem), Cks1 (Invitrogen), Csn5 (Santa Cruz), myc (Covance) and Rbx1/Roc1 
(Biosource). 
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Figure Legends 
 
FIGURE 1. Characterization of in vitro deneddylation assay components and 
enzymatic properties of human CSN. 
A, Purified CSN from HEK293 cells was fractionated by SDS-PAGE and analyzed by 
silver staining to check for purity and stoichiometry of enzyme subunits. 
B, Purified Cul1–Rbx1 (50 nM) conjugated with [32P]-labelled HPN8 was incubated with 
1 nM CSN in a total reaction volume of 50 µl. At the indicated time points, aliquots were 
quenched and evaluated by SDS-PAGE followed by autoradiography. 
 C, Phosphorimager quantification of B. 
D, The initial rate of deneddylation by 0.8 nM CSN at different concentrations of 
substrate is plotted. KM and kcat were estimated by fitting the curve to the Michaelis-
Menten equation.  
 
FIGURE 2. F-box–Skp1 and substrate inhibit deneddylation by CSN. 
A, Purified Cul1–Rbx1 (500 nM) conjugated with [32P]-labeled HPN8 was preincubated 
for 10 minutes with 600 nM of Fbw7–Skp1 or b-TrCP–Skp1, followed by the addition of 
1 nM CSN. At the indicated time points, aliquots were quenched and evaluated by SDS-
PAGE (left panel) followed by phosphorimager quantification (right panel). Rates (fmol 
Nedd8 released from Cul1/sec) are indicated to the right of each curve. The total reaction 
volume was 25 µl. 
B, Same as A, except [32P]-HPN8-Cul1–Rbx1 substrate at 50 nM was mock-incubated or 
preincubated with 100 nM Skp1–Skp2–Cks1 in the presence or absence of 1 µM 
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phospho-p27–cyclin E–Cdk2 (p27).  Total reaction volume was 50 µl. The asterisk 
indicates [32P] label incorporated into p27. 
C, Same as A, except [32P]-HPN8-Cul1–Rbx1 substrate was at 50 nM, Fbw7–Skp1 was at 
100 nM, and phospho-cyclin E–Cdk2 (CycE) was at 500 nM.   
D, Same as C, except that Fbw7–Skp1 was omitted.  
E, [32P]-HPN8-Cul1–Rbx1 substrate at 100 nM was preincubated 5 min. with 300 nM 
Skp2–Skp1 plus or minus Cks1. Following assembly of SCFSkp2 complexes, the reactions 
were supplemented with ubiquitylation components (1 µM ubiquitin, 400 nM E1, 100 nM 
Cdc34, plus or minus 500 nM phospho-p27–cyclin E–Cdk2), incubated for 10 minutes, 
supplemented with ATP and Mg2+ to initiate ubiquitylation, and incubated a further 20 
minutes prior to addition of CSN (0.8 nM). Total reaction volume was 50 µl. At the 
indicated time points, aliquots were quenched and evaluated by SDS-PAGE followed by 
phosphorimaging (top panel). Quantification of the phosphorimager scans is shown in the 
bottom panel. 
 
FIGURE 3. Proteins that bind the C-terminal domain of Cul1 inhibit deneddylation 
A, [32P]-labeled HPN8-Cul1–Rbx1 (25 nM) was incubated for 10 min with 1 µM of the 
indicated factor prior to addition of 0.8 nM CSN. At the indicated time points, aliquots 
were quenched and evaluated by SDS-PAGE followed by phosphorimager quantification. 
The total reaction volume was 40 µl. 
B, Same as A, except that substrate was 150 nM and was preincubated with the indicated 
final concentration of Cand1 prior to adding CSN.  
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C, Same as B, except that Cand1 (250 nM) and CSN (0.8 nM) were held constant while 
the concentration of substrate was varied. The data were fitted to the Michaelis–Menten 
equation to estimate kcat and KM. 
D, [32P]-labeled HPN8-Cul1–Rbx1 (50 nM) was preincubated with 200 nM Skp1–Skp2–
Cks1 for 10 minutes prior to addition of the indicated final concentrations of Cand1. 
Following a further 10 min precincubation, CSN (0.8 nM) was added. At the indicated 
time points, aliquots were quenched and evaluated by SDS-PAGE followed by 
phosphorimager quantification. 
E, Same as B, except that substrate was 50 nM and Cul1–Rbx1 was titrated. 
 
FIGURE 4. CSN forms a stable complex with both neddylated and unmodified Cul1. 
A, Purified SCFSkp2–Cks1 (600 nM) was incubated for 15 min either in the presence (top 
panel) or absence (bottom panel) of 300 nM purified CSN. Complexes were passed 
through a Sephadex-200 size exclusion column and every third fraction was separated by 
SDS-PAGE and Western blotted with antisera to the indicated proteins. 
B, The indicated HA-tagged Cul1 constructs were transfected into HEK293 cells. 
Twenty-four hours post transfection, lysates were generated and HACul1 was 
immunoprecipitated with anti-HA antibody. IPs were fractionated by SDS-PAGE and 
western blotted with antisera to the indicated proteins.  Cul1 was detected with anti-HA. 
xRING and xSkp1 refer to point mutants of Cul1 that were deficient in binding Rbx1 and 
Skp1, respectively. K720R has an arginine substitution at the Nedd8 conjugation site 
(lysine 720). 
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C, The indicated FLAG-tagged Csn5 constructs were transfected into HEK293 cells. 
Twenty-four hours post transfection, lysates were generated and FLAGCsn5 was 
immunoprecipitated with anti-FLAG antibody. IPs were fractionated by SDS-PAGE and 
Western blotted with antisera to Csn5 and Cul1 as indicated.  EV refers to empty vector. 
ASA refers to a double point mutation that inactivates the JAMM domain of Csn5. 
 
FIGURE 5. CSN inhibits ubiquitylation by unmodified SCF 
A, SCFβTrCP (100 nM) and ubiquitylation components (1 µM ubiquitin, 400 nM E1, 100 
nM UbcH5C, 600 nM [32P]-labeled-phospho-β catenin peptide) were incubated either in 
the presence or absence of 300 nM CSN for 10 min, after which ubiquitylation reactions 
were initiated by addition of ATP and Mg2+. Time points were harvested at the indicated 
times, fractionated by SDS-PAGE, and subjected to phosphorimager quantification.  
B, Same as A, except that 100 nM Cdc34 was used in place of UbcH5C. 
 
FIGURE 6. Regulation of CRLs by reversible neddylation 
See text for details. Transitions marked by single arrows are vectorial. Intermediates at 
steps 5 and 6 could re-form new CRL complexes by binding a different substrate 
receptor–adaptor module (dashed and curved lines, respectively) 
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Supplemental Fig 1 
 
 
 
 
A,B Purified, Nedd8-conjugated Cul1 used for kinetic studies was fractionated by SDS-
PAGE and either stained directly with Coomassie Blue (B) or transferred to nitrocellulose 
and immunoblotted with anti-Cul1 antibodies (A). CTD refers to the C-terminal domain 
of the split-n-coexpress Cul1 used in these studies. 
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C, Cul1 was conjugated with either wild type Nedd8 or tagged HisPKA-Nedd8 (HPN8). 
Neddylation was terminated with MLN4924 and substrates were diluted into a 
deneddylation reaction as described in Materials and Methods. The background of 
unmodified substrate was high because neddylated Cul1–Rbx1 was not enriched prior to 
the assay. The total reaction volume was 50 µl. 
D, HPN8-Cul1–Rbx1 substrate (50 nM) was incubated with 0.5 nM of CSN purified 
from either 293 cells or baculovirus-infected insect cells. The total reaction volume was 
50 µl. 
E, Same as D except 0.8 nM CSN purified from 293 cells and E. coli were compared. 
F, Rate curves for deneddylation at different concentrations of substrate. These curves 
were used to construct the graph in Fig. 1D. 
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Supplemental Fig 2 
 
  
 
A, Plasmids encoding either wild type (wt) b-TrCP tagged with 5 copies of the myc 
epitope or a mutant (6-Ala) in which 6 residues that contact b-catenin phosphopeptide 
were mutated to alanine were transfected into 293 cells. After 24 hours, lysates were 
prepared and subjected to immunoprecipitation with anti-myc antibodies. Samples were 
fractionated by SDS-PAGE and immunoblotted for Cul1. Cul1 associated with b-TrCP 
was largely in the neddylated state, but this bias was modestly reduced for the mutant b-
TrCP.  
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B, Plasmids encoding either wild type (wt) myc-tagged Skp2 or mutants in which the 
leucine rich repeats were deleted (∆LRR) or the Cks1-binding site DLSD was converted 
to ALSA were transfected into 293 cells.  After 24 hours, lysates were prepared and 
subjected to immunoprecipitation with anti-myc antibodies.  Recovered proteins were 
fractionated by SDS-PAGE and immunoblotted for the indicated proteins. Note that 
contrary to b-TrCP, most of the Cul1 associated with Skp2 was in the deneddylated state. 
This may be due to an active ability of Skp2 to recruit functional CSN, because both the 
ALSA and ∆LRR mutants of Skp2 were associated primarily with neddylated Cul1 and 
exhibited a strong reduction in Csn5 binding.  
 
 
 
  
	   63	  
Supplemental Fig 3 
 
 
Effect of Skp1 loops on inhibition of CSN. Fbw7 was co-expressed with either wild type 
Skp1 to generate Fbw7(FL) or with Skp1 lacking the two internal acidic loops to generate 
Fbw7∆∆. The resulting proteins were mixed with [32P]-labeled HPN8-Cul1–Rbx1. CSN 
(1 nM) was added to a total reaction volume of 50 µl and samples were withdrawn and 
quenched at the indicated time points. Reaction progress was evaluated by SDS-PAGE 
(left panel) followed by quantification on a phosphorimager (right panel). Reaction rates 
in fmol Nedd8 released from Cul1/sec are shown to the right of each curve.  
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Supplemental Fig. 4 
 
 
 
A, Effect of Cdc34 concentration on inhibition of SCFFbw7 by CSN. Fbw7–Skp1, Cul1–
Rbx1, and [32P]-labeled cyclin E phosphopeptide were mixed together in either the 
absence or presence of CSN for 3 minutes at room temperature to generate a pair of 
samples referred to as ‘set 1’. In parallel, different concentrations of Cdc34 were mixed 
with E1 enzyme, ubiquitin, and ATP at room temperature for 3 minutes to allow ubiquitin 
charging to occur, yielding samples referred to as, ‘ set 2’. An ubiquitylation reaction was 
initiated by mixing together a tube from set 1 with the appropriate tube from set 2. 
Samples were withdrawn at the indicated times, quenched, fractionated by SDS-PAGE, 
and evaluated by phosphorimaging.  A gel image is shown on the left and quantification 
of the image on the right. 
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B, Effect of Cyclin E substrate peptide on inhibition of SCFFbw7 by CSN. Fbw7–Skp1, 
Cul1–Rbx1, and varying concentrations of [32P]-labeled cyclin E phosphopeptide were 
mixed together in either the absence or presence of CSN for 3 minutes at room 
temperature to generate samples referred to as ‘set 1’. In parallel, Cdc34 was mixed with 
E1 enzyme, ubiquitin, and ATP at room temperature for 3 minutes to allow ubiquitin 
charging to occur, yielding a sample referred to as reaction 2. An ubiquitylation reaction 
was initiated by mixing together a tube from set 1 with an aliquot of reaction 2. Samples 
were withdrawn at the indicated times, quenched, fractionated by SDS-PAGE, and 
evaluated by phosphorimaging.  A gel image is shown on the left and quantification of 
the image on the right. 
 
 
 
 
 
Supplemental Table 1 
 
[S] (nM) Rate (nM product formed/nM CSN/second) Rate (fmol free 
Nedd8/second) 
50 0.16 6.6 
 
100 0.29 13.1 
150 0.50 20.5 
200 0.53 24.4 
250 0.65 27.5 
500 0.77 32.2 
750 0.90 37.4 
1000 0.95 38.9 
1500 0.96 41.4 
2000 0.94 40.4 
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Supplemental Table 2 
 
Substrate Initial Rate  
(nM product/nM 
CSN/sec) 
Initial Rate  
(fmol free Nedd8/sec) 
N8-Cul1 0.13 2.4 
N8-SCFSkp2/Cks1 0.10 2.4 
N8-Cul1 + Dcn1-3 0.06 1.4 
N8-Cul1 + Nedd8 0.06 1.4 
N8-Cul1 + Ubc12 0.04 1.1 
N8-Cul1 + UbcH5C 0.04 1.1 
N8-Cul1 + Dcn1-3 + Ubc12 0.02 0.59 
N8-Cul1 + Ubxd7 0.02 0.32 
N8-Cul1 + Cand1 0.02 0.30 
N8-Cul1 + Cdc34 0.02 0.28 
N8-Cul1 + Cul1 0.01 0.17 
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Supplemental Table 3 
List of proteins used in this study 
Protein Construct Strain Expression Purification Comments Reference 
Cdc34b pET11 His 
TEV Cdc34 
RDB 
2222 
E. coli Ni-NTA, 
TEV digest, 
S200 
- (Saha and 
Deshaies 
2008) 
UbcH5c pGEX TEV 
UbcH5c 
RDB 
1973 
E. coli GST, TEV 
digest (on 
beads), S75 
- (Saha and 
Deshaies 
2008) 
Cul1 
NTD 
Rbx1-
Cul1 
CTD 
pAL Cul1 
NTD, pCool 
Rbx1 Cul1 
CTD 
RDB 
2080 
RDB 
2081 
E. coli GST, 
Thrombin 
digest, 
Mono S, 
S200 
Co-
expression 
(Li, 
Pavletich 
et al. 
2005) 
b-TrCP-
Skp1 
(139-
569) 
 
Fbw7-
Skp1 
GST bTrCP-
Skp1 
 
GST Fbw7-
Skp1 
- 
 
 
 
 
- 
Hi5 insect 
cell 
 
Hi5 insect 
cells  
GST, 
thrombin 
digest, 
Mono Q, 
S200 
GST, 
thrombin 
digest, S200 
Co-
expression 
 
Co-
expression 
(Li, 
Pavletich 
et al. 
2005) 
 
(Pierce et 
al., 
submitted) 
His8-
PKA-
Nedd8 
pJexpress414 RDB 
2673 
E. coli Ni-NTA, 
S75 
 (this 
study) 
Nedd8 
E1 
GST-Nedd8 
E1 
RDB 
2037 
E.coli GST, 
thrombin 
digest, S200 
Co-
expression 
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Ubc12 GST-Ubc12 RDB 
2036 
E. coli GST, 
thrombin 
digest, S75 
  
Cand1 GST-Cand1 RDB 
2049 
E. coli GST, 
thrombin, 
Mono Q, 
S200 
  
Skp1-
Skp2 
GST-Skp1 
Skp2 
RDB 
2047 
E. coli GST, 
thrombin, 
Mono Q, 
S200 
Co-
expression 
 
Cks1 
 
Fbw7-
Skp1∆∆ 
 
 
phospho-
cyclin E-
Cdk2 
 
 
phospho-
p27 
 
cyclin E-
Cdk2 
 
 
CSN 
 
 
CSN 
 
CSN 
GST-Cks1 
 
GST Fbw7-
Skp1 
 
 
 
 
 
 
GST-p27 
 
 
GST-Cdk2-
Cyclin E 
 
 
FLAG-Csn2 
 
 
 
RDB 
2046 
 
- 
 
 
 
 
 
 
 
- 
E. coli 
 
Hi5 insect 
cells 
 
 
 
 
 
 
E. coli 
 
 
Hi5 insect 
cells 
 
 
293 cells 
 
 
E.coli 
 
Insect cells 
GST, 
thrombin, 
S75 
GST, 
thrombin, 
S200 
 
 
 
 
 
 
GST, 
thrombin, 
S75 
 
GST, 
thrombin, 
S200 
 
 
FLAG, 
S200 
 
 
Co-
expression 
 
 
 
 
 
 
 
 
 
Co-
expression 
 
 
 
 
 
 
 
B. 
Clurman 
 
 
(Saha and 
Deshaies 
2008) 
(Saha and 
Deshaies 
2008) 
 
(this 
study) 
 
 
N. Zheng 
 
R. Enchev 
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Supplemental Table 4 
 
List of plasmids used for transfection in this study 
Protein Construct Mutation RDB Tag   
Cul1 pCS2 - 942 N-term 
5Xmyc 
Cul1K720R pCS2 K720R 2713 N-term 
5Xmyc 
Cul1xRING pCS2 535DFSIQVL→RRSIQEE 2712 N-term 
5Xmyc 
Cul1xSkp1 pCS2 M43S, Y46K, Y50K, 
Y139A, R142D 
2710 N-term 
5Xmyc 
Csn5 pcDNA - 1419 N-term 
FLAG 
  
Csn5 ASA 
Myc-b-TrCP 
Myc-b-TrCP-
6Ala 
 
Myc-Skp2 
Myc-Skp2-
ALSA 
Myc-Skp2-
∆LRR 
pcDNA 
pcDNA 
pcDNA 
 
pCS2 
pCS2 
pCS2 
 
 
H118A, H120A 
- 
Y271A, R285A,R431A 
S448A, R474A, Y488A 
- 
D316A, D319A 
Stop codon after codon 
210 
1500 
865 
1985 
 
939 
1983 
1982 
N-term 
FLAG 
N-term 
5Xmyc 
N-term 
5Xmyc 
 
N-term myc 
N-term myc 
N-term myc 
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Chapter 3: Kinetic Analysis of 
CSN mediated SCF 
Deneddylation 
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Abstract 
 In this work, we sought to better understand the mechanisms regulating how 
Cullin-RING Ligases (CRL) are deactivated by the deneddylation activity of the Cop9 
Signalosome (CSN). Using a series of fluorescent and biochemical assays we developed 
for this work,to measure the biochemical characteristics of CSN, we have discovered that 
a conformation change in the catalytic subunit of CSN, CSN5, dramatically increases the 
affinity for CRLs and activates the isopetidase activity. Our data show that while contacts 
with the N-terminus of CSN4 do indeed increase the substrate binding affinity and 
activity of CSN, the majority of the binding energy comes from CSN5 itsself. The 
dramatic shift in affinity is controlled by the Ins-1 in both This is achieved by the binding 
of the E104 residue of Ins-1 to the catalytic zinc in the inactive, low affinity state of CSN, 
and T103 and E104 to some undetermined residues in the active, high affinity state. 
Furthermore, my data suggests we have shown that the inhibition of deneddylation comes 
primarily from competitive inhibition by E2 enzymes as opposed to the current model 
that substrates sterically block the binding of CSN.  
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Introduction 
Cellular homeostasis is dependent on an intricate control of both the small 
molecules bathing cells in their environment as well as regulation of the macromolecules 
derived from the cells themselves. In particular, constant turnover of proteins within a 
cell is required for the maintenance of a properly folded and fully functional repertoire as 
well as limiting the expression of certain proteins to distinct periods of time when their 
activities are necessary. One of the major mechanisms by which cells achieve 
homeostatic regulation of their proteins is through the marking and degradation of 
proteins by the Ubiquitin-Proteasome System (UPS). When the fate of a protein has been 
decided by any of a variety of factors, ubiquitin E1 and E2 enzymes aid in the transfer of 
ubiquitin molecules, as a post-translation modification, to substrates through E3 Ligases 
which serve to both recognize substrates and catalyzes their ubiquitination (Deshaies and 
Joazeiro 2009).  
 One of the largest classes of ubiquitin E3 ligases is the family of Cullin-RING 
Ligases (CRLs), which constitute a heterometric complex capable of transferring 
ubiquitin to many hundreds of substrates. The cullin family of proteins provide a long flat 
functional scaffold upon which the system is based. On their c-termini they are intimately 
bound to a RING domain protein (Rbx1/Roc1/Hrt1), which serves to activate the E2 
Ubiquitin Conjugating enzymes to directly transfer ubiquitin to its substrates. On their n-
termini they bind adaptor molecules that mediate the binding of substrate receptors and 
substrates. Although mechanistically unclear, the modification of CRLs by Nedd8 (the 
closest homolog of ubiquitin) appears to alter the quaternary conformation of the CRL to 
close the gap between the substrate and E2 to dramatically increase the rate of ubiquitin 
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transfer (Duda, Borg et al. 2008) (Saha and Deshaies 2008) (Deshaies and Joazeiro 2009, 
Echalier, Pan et al. 2013). 
 Although the activation of CRLs by neddylation is required for their catalytic 
activity in vivo, it has long been understood that negatively regulating CRL activity 
through deneddylation by the Cop9 Signalosome (CSN) is required to maintain 
appropriate levels of substrate receptors and efficiently degrade CRL substrates (Cope 
and Deshaies 2006). In fact, the ability of many substrates of CRLs such as c-myc, β-
catenin and Hif1α to serve as proto-oncogenes, as well as the known roles of CRL 
substrate receptors such as Fbw7, β-TrCP, and VHL as tumor suppressor, implies that 
maintaining efficient CRL function plays a critical role in cellular homeostasis (Skaar, 
Pagan et al. 2013).  
At the time of its discovery in the last decade, the effect on both substrate receptors 
and their respective substrates upon the loss of deneddylation by CSN appeared 
paradoxical. However, the mechanisms behind this phenomenon became clearer with the 
recent discovery that efficient exchange between substrate receptors is mediated by a 
protein exchange factor CAND1 (Pierce, Lee et al. 2013). It was found that in order for 
CAND1 to perform its biochemical activity to allow new substrate receptors to bind, the 
CRL must first be deneddylated. Thus, in the absence of CSN activity to remove and 
deactivate CRLs, substrate receptors are less capable of dissociating from the CRL and 
become substrates for ubiquitination. This cannibalism of substrate receptors by the 
complex increases the cellular levels of CRL substrates by two mechanisms: 1) the levels 
of substrate receptors scouting and bringing substrates to the E3 are reduced and 2) 
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without proper deneddylation, free substrate receptor bound to substrates cannot gain 
access to the scaffold.  
Since the initial reports of the discovery of CSN and its role in regulating the 
organismal response of A. thaliana to cycles of dark and light conditions and the 
demonstration of its definitive catalytic function as a deneddylase, very little had been 
elucidated about its enzymatic activity (Wei and Deng 1992). Over the last few years, 
however, there has been a rapid ramp up of tools and structural determinations that have 
given new insight into the mechanisms of CSN’s deneddylation activity. Recently 
published crystal structures have given us a structural understanding of why CSN is 
inactive against fluorescence UBLs and model deubiquitinase (DUB) substrates, which 
have been crucial in the study of other isopeptidases. The highly conserved Ins-1 loop of 
CSN5 appears to be bound to, or near, its catalytic site and thus precludes the positioning 
of the isopeptide bond in the catalytic core of CSN in the absence of some sort of 
conformational change (Echalier, Pan et al. 2013) (Lingaraju, Bunker et al. 2014).  
We now understand that a major contact for CSN is the N-terminus of CSN2 
binding the C-terminus of Cul1 (Enchev, Scott et al. 2012). However, there is some 
evidence to suggest that CSN4 might also be making contacts with the Rbx1 protein and 
thus forcing a conformational change in the quaternary structure of CSN allowing the 
Ins-1 loop of CSN5 to shift out and open up its catalytic center (Lingaraju, Bunker et al. 
2014). With the development of new biochemical assays that have allowed determination 
of CSN’s kinetic parameters as well as structural insights, we can now use mutagenesis to 
perturb the portions of its subunits to better understand their role in regulating CSN’s 
functional regulation.  
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Results 
In order to mechanistically understand how the Cop9 Signalosome activity is 
regulated, we sought out to measure the microscopic kinetic rates of the entire reaction 
deneddylation reaction. We, and others, have published data on the kinetic parameters of 
Cul1 deneddylation, including kcat and Km, it is clear from the data that the reaction is 
either diffusion-limited or nearly diffusion-limited and thus may not follow classic 
Michalis-Menton kinetics. The strict definition for diffusion limited reactions is kcat/Km  
of 10^9 M-1 sec-1 for reactions involving small molecules, but for interactions involving 
large protein complexes a kcat/Km on the order of 10^6 M-1 sec-1, as has been reported for 
the deneddylation of Cul1 and Cul4a, is considered diffusion limited (Emberley, 
Mosadeghi et al. 2012) (Lingaraju, Bunker et al. 2014). The reported kcat/Km of 5x10^6 
M-1 sec-1, in the case of CSN deneddylating Cul1, implies that after binding, there is 
greater chance of a reaction occurring rather than the two proteins dissociating. This 
implies that we cannot make the assumption that Km=Kd. In order to be able to measure 
the affinity of CSN for different SCF complexes we sought to develop an assay with an 
optical read-out to measure both equilibrium binding constants and the kinetic binding 
rates between the two complexes.  
We developed an environmentally sensitive assay by using sortase-mediated 
transpeptidation to conjugate to the C-terminus of split’n’co-express Cul1-Rbx1, a 
peptide of sequence GGGGK that was modified with a dansyl fluorophore, to yield C1D 
(Popp, Antos et al. 2007). The binding of CSN to the C-terminal domain of Cul1 alters 
the local environment of the dansyl dye, resulting in an increase in its quantum yield, 
which can be used to assay binding (Fig. 1A). After affirming that CSN could in fact 
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increase the fluorescence C1D, we sought to validate the assay by testing buffer 
conditions and attempting to chase away the signal increase upon CSN binding. Neither 
the addition of the Hepes buffer our CSN was purified in (data not shown) nor increasing 
amounts of Ovalbumin altered the fluorescence of C1D (Fig S1B). Unfortunately, we 
were not able to chase away the signal increase by CSN with the addition of unlabeled 
Cul1-Rbx1 (data not shown). Since it has been reported that some RING domain ligases, 
including CRL3, proteins might act as dimers, we sought to test whether Cul1 
dimerization, through Cul1 or Rbx1, was obscuring our results by binding CSN but also 
binding and increasing the fluorescence of C1D (Fig. S1A).  Indeed, we found that this 
was the case when we added Cul1-Rbx1 alone to C1D and observed a binding affinity of 
652.2 nM. In the case of neddylated Cul1, C1ND, unlabeled Cul1-Rbx1, bound with an 
apparent affinity of 110.7 nM (Fig S1C). We then sought to determine whether another 
cullin, Cul3-Rbx1, or another cullin assembled with different RING protein, Cul5-Rbx2, 
could outcompete CSN for binding to C1D. Cul3-Rbx1 was able to heterodimerize with 
an increase the fluorescence of C1D and thus was not suitable as a chase. Cul5-Rbx2 did 
not appear to bind with C1D, but unfortunately, Cul5-Rbx2 also did not chase away CSN 
(Fig. S1D). This is perhaps due to the poor binding affinity between CSN and 
unneddylated Cul5 (Fig. 3C). In fact, we do not see a great deal of Cul5 binding CSN in 
our mass spectroscopic assays.  
Given the observation that C1D was able to dimerize with Cul3-Rbx1, but not to 
Cul5-Rbx2, we hypothesized that the ability of cullins could be partially mediated by the 
RING domains. When we added a large surplus of Cul1-Rbx1ΔRING, we were no longer 
able to increase the fluorescence signal of dansyl (Fig. 1A). When added in excess, Cul1-
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Rbx1ΔRING was able to chase away the signal increase of C1D binding to CSN. It remains 
to be determined whether Cul1-Rbx1 can dimerize in the absence of the RING domain, 
or whether binding to a Cul1-Rbx1ΔRING is incapable of increasing the fluorescence of the 
dansyl fluorophore in the dimerized state.  
 To start our characterization of the deneddylation reaction we first set out to 
measure the equilibrium binding of CSN to different states of SCFs. We titrated 
increasing amounts of wild-type CSN against C1D and determined that they bind with a 
Kd of 305 nM (Fig. 1C and Table 1). In order to account for the effects that Nedd8 might 
have on the off-rate of the complex immediately after the cleavage of the isopeptide bond 
we repeated this experiment with the addition of 5 µM Nedd8 and found a slight shift of 
the Kd to 230 nM (Fig. S2 and Table 1). Both 305 nM and 230 nM closely match the 
reported Ki  (250 nM) of unneddylated Cul1-Rbx1 for inhibiting the deneddylation of 
Cul1 of 250 nM (Emberley, Mosadeghi et al. 2012). The implication is that CSN binds its 
Cul1-Rbx1product with fairly high affinity and that Nedd8’s surface contributes very 
little to the binding energy to the binding of CSN. The minor effect of Nedd8 also agrees 
with the Emberley et al. finding that Nedd8 on its own was a poor inhibitor of 
deneddylation.  
Next, we wanted to measure the affinity of CSN for its substrate. In order to do 
this, we substitute one the zinc chelating residues to alanine, H138A. The absence of the 
zinc molecule in this conformation renders the CSN inactive, but we found it otherwise 
normal in assembly into complex and purifying off of ion exchange and size exclusion 
chromatography columns. The binding affinity between CSNH138A and C1ND is 
incredibly tight at 1.64 nM (Fig. 4A). In fact, the Kd for CSNH138A binding to C1ND was 
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two orders of magnitude lower than that of wild-type enzyme to C1D and the Kd for 
binding of CSNE76A to C1ND at 119 nM. This led us to test whether the catalytic zinc was 
required for maintaining CSN in a low affinity confirmation for Cul1. Indeed, when we 
tested the ability of CSNH138A to bind unneddylated C1D, we found that the binding 
affinity was 10.1 nM (Fig. 4B), representing ~30-fold increase in binding affinity to its 
product as compared to wild-type enzyme, but less than 10-fold worse compared to its 
substrate.  
In order to determine the equilibrium binding constants of CSN for its substrate, 
N8-Cul1-Rbx1, we performed analogous experiments to those above, but with a 
catalytically dead JAMM domain mutant CSNE76A instead of the zinc chelating mutant 
(Echalier, Pan et al. 2013). We found that the Kd of CSNE76A for C1ND was 119 nM (Fig. 
1E and Table 1). This mutant also had a subtle effect when binding to C1D at 182 nM 
(Fig. 1D and Table 1).  The contributions of Nedd8 and the conformational changes in 
Cul1 and Rbx1 in response to neddylation appear to confer only subtle increases in 
binding energy regardless of which mutant we are testing.  In contrast to this, the 
catalytic core of CSN5 appears to have a great influence on the binding of the entire 
complex to Cul1-Rbx1 by two orders of magnitude or more.  
In order to better understand how CSN5, the catalytic subunit of CSN, contributes 
to bind, we produced CSN complex missing CSN5, CSNΔ5. We found that CSNΔ5 was 
dramatically in the Kd of that CSNΔ5 and C1D was at least 1178 nM (Table 1), >3-fold 
weaker than the weakest interaction studied with wild-type enzyme. This number might 
in fact be even high given that we did not have enough protein to properly saturate the 
binding between these two protein complexes. Because this enzyme was catalytically 
	   79	  
dead, it allowed us to measure its affinity for C1ND, which we found to be nearly 
identical to the Kd between CSNΔ5 and unneddylated Cul1 at 1086 nM (Table 1.). Thus it 
appears that CSNΔ5 cannot distinguish between the neddylated and unneddylated form of 
Cul1-Rbx1, meaning that CSN5 plays a crucial role recognizing and binding to Cul1 in 
all states. 
Based on the complete CSN crystal structure, the catalytic zinc of the JAMM 
domain is bound in an inactive state by glutamate 104 of the critical regulatory loop Ins-
1, while the structure of monomeric CSN5 shows that arginine 106 was mediating 
binding to aspartate 151 to sterically block an isopeptide bond from entering the catalytic 
groove. The authors even reported that an E104A mutation was active against a model 
substrate, ubiquitin-rhodamine, while monomeric CSN5 with a R106A mutation was able 
to deneddylated Cul1-Rbx1. In order to systematically look at the role of this loop, we 
developed a cell-based assay by which we could quickly test if any mutations in Ins-1 
could lead to changes in cullin neddylation. Specifically, if binding of the autoinhibitory 
loop to the active site of CSN was lost we expected to see activation of CSN and a 
reduction in cullin neddylation in vivo.  We did this by making stable 293T cell lines 
expressing Flag-tagged MSCV vectors harboring point mutations for each of the four 
highly conserved residues in Ins-1: T103I, E104A, T105A and R106A. We decided to 
make T103I because this mutant is known to cause severe developmental defects in 
drosophila (Suh, Poeck et al. 2002). In order to better incorporate our point mutants into 
intact CSN complexes, we then created CRISPR vectors to knockout endogenous CSN5, 
but not our mutants, by targeting upstream sequence that are not present in the MSCV 
construct. Strikingly, we noticed that two mutations, CSN5T103I and CSN5E104A, appeared 
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to behave oppositely to what we expected. Both of those mutants led to a 
hyperneddylation of cullins under asynchronous growth conditions (Fig. 3A). CSN5T105A 
and CSN5R106A, although highly conserved, did not show this phenotype under our assay 
conditions.   
 Since we knew that the loss of a zinc atom could lead to a significant increase in 
the affinity between CSN and Cul1, we wondered if the hyperneddylation we saw in vivo 
was caused by product inhibition. Specifically, does a loss of binding of the 
autoinhibitory loop, Ins-1, lead to a tight binding between CSN and Cul1, thus reducing 
the rate of deneddylation under multi-turnover conditions in the cell? To test this 
hypothesis, we treated our cell lines with the neddylation inhibitor MLN4924 (Soucy, 
Smith et al. 2009) to completely deneddylate all cullins and test whether CSNT103I and 
CSNE104A mutants were able to immunoprecipitate more unneddylated Cul1-Rbx1 than 
wild-type. Much to our surprise, the two mutations behaved oppositely. The CSNE104A 
lead to a remarkable increase in co-immunoprecipitated Cul1-Rbx1, while CSN5T103I co-
immunoprecipitated slightly less Cul1 out of lysate (Fig. 3B). Interestingly, The T103I 
mutation was epistatic to E104A, because the T103I/E104A double mutant behaved the 
same as T103I and did not confer increased binding affinity to unneddylated Cul1.   
To better quantify this effect and evaluate its generality, we set out to compare 
both of these mutants under these conditions by using SILAC Mass Spectroscopy. Of all 
of the species, it appears that Cul4 bound the largest fraction of CSN, while Cul1 bound 
the least. As expected, we saw a prominent increase in Cul1 and Cul2 bound to CSNE104A 
and a smaller, but consistent, increase in Cul3, Cul4A and Cul4B (Fig. 3C). The milder 
effects on these latter cullins might be due to the fact that a high mole fraction of each is 
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alrady bound to wild-type CSN. Much like the IP western data, we saw a reduction in 
binding of CSN5T103I to all cullins except Cul5.  There were significant differences in 
which substrate receptors that each mutant preferred to bind to, but we were unable to 
discern any obvious patterns with out current knowledge.  
To build upon our cell lysate assay, we sought to elucidate the kinetic parameters 
contributed by the binding of E104 to the zinc atom that is required for the lower affinity, 
autoinhibited, state of CSN. We tested the binding affinity between CSNE104A for 
unneddylated C1D and indeed found that it was significantly tighter than the Kd of wild-
type enzyme at 25.8 nM (Fig 4C). This finding suggests that since loss of either binding 
partner keeping Ins-1 in the active groove of CSN5 will lead to a higher affinity for 
CSN’s product, and that the binding of E104 to the catalytic zinc is required for the low 
affinity state. Unfortunately, because this mutant is still active, we were unable to 
determine the equilibrium binding of constants for Nedd8-conjugated Cul1-Rbx1.  
Next, we sought to test the effects of CSNE104A in vitro and address two 
assumptions. First, based on the cellular data we hypothesized that we might see a 
reduction in multi-turnover deneddylation due to product inhibition. When we compared 
wild-type CSN to CSNE104A at saturating concentrations of substrate to measure the 
multi-turnover kcat for N8-Cul1-Rbx1 deneddylation, we saw that the CSNE104A was 
indeed slower than wild-type enzyme (Table 2). We also increased the concentration of 
substrate with both enzymes to see if the point mutant appeared to be slower because of a 
shift in Km, but saw that no appreciable difference (Fig. 4D). This result establishes two 
points: 1) that the E104A point mutant has reduced deneddylation activity and 2) that the 
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difference is not due to differences in on-rate, since the reaction was done with saturating 
concentrations of substrate.  
In order to test whether E104A was product inhibited or whether E104 is involved 
in stabilizing other conformations of Ins-1, we then tested the single-turnover kcat by 
deneddylating low concentrations of N8-Cul1-Rbx1 by saturating concentrations of CSN 
in molar excess over N8-Cul1-Rbx1. Unexpectedly, we saw that the single-turnover kcat 
of E104A mutant was a) slower than wild-type and b) the same as the kcat for multit-
urnover conditions (Table 2). The implication of this result is that E104 may also helping 
to stabilize the activate conformation.  
Next, we sought to test the proposed hypothesis, based on interpretations of the 
available crystal and cryoEM structures, that the activation of CSN is mediated through 
the binding of the N-terminal domain of Csn4 to Rbx1 (or some portion of the C-
terminus of Cul1) to alter the quaternary structure of CSN by sterically moving a loop in 
Csn6, forcing it to shift and rearrange Csn5. In this rearrangement, it is proposed that Ins-
1 is pulled out of the catalytic cleft of Csn5 and this activates the enzyme. Indeed, the 
removal of the loop in CSN6 was reported to increase the kcat of CSN by about six-fold 
(Lingaraju, Bunker et al. 2014)). In order to test how much binding energy the N-
terminus of CSN4 was contributing to the activation of CSN, we set out to test the kinetic 
parameters of a CSN complex missing the N-terminus of CSN4 (CSN4Δn). While the 
activity of this mutant was reduced, we found that the enzyme was still active. Although 
we could not measure its affinity for N8-Cul1, we did establish that its Km N-Cul1-Rbx1 
was 562 nM. Clearly, this mutant is a less effective enzyme with significant catalytic and 
binding defects compared to wild-type CSN, but the effects were much less dramatic than 
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that of CSNΔ5. Taken together, our results suggest that while the N-terminus of CSN4 
makes contact with the SCF, this binding is not the main trigger for activating CSN, 
because in the absence of CSN5, it cannot maintain CSN in an active conformation.   
We next sought to test whether assembly of Cul1 with different classes of Fboxes 
would have large effects on binding. We tested the binding of CSN to both unneddylated 
SCFSkp2 and SCFFbw7 and found that neither complex was able to increase the binding 
affinity to CSN by more than a few fold (Fig. 2A, 2B and Table 1). This was also the case 
when neddylated SCFs were tested with a catalytically dead mutant, CSNH138A, which is 
incapable of chelating the catalytic zinc and neddylated SCFs (Fig 2C and 2D).   
Since we could not see an appreciable effect of CSN binding under equilibrium 
binding conditions, we sought to determine their effect on on-rates and catalysis. Using a 
Stopped-flow apparatus, we determined that both mutant and wild-type CSNs bound all 
forms of Cul1-Rbx1 with a kon value within two-fold of 2x10^7 M-1 sec-1, implying that 
the any difference in the Kd between SCFs and N8-SCFs was primarily influenced by off-
rate rather than on-rate (Table 1).  Interestingly, all of the complexes bind CSN very 
quickly and nearly at a diffusion-limited rate. While it is possible to for proteins to bind 
more quickly than we report here, those instances generally require electrostatic 
interactions that help reduce the dimensionality of the search during formation of a stable 
complex, as is the case for the acidic tail of Cdc34 and the basic canyon of Cul1 (Kleiger, 
Saha et al. 2009). 
Next, we measured the kcat under single-turnover conditions to test whether 
Fboxes could affect. Under single-turnover conditions the off-rate is not relevant.  In 
addition, because the reaction contains a 50-fold excess of enzyme at a saturating 
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concentration, the on-rate of the enzyme should not be rate-limiting. Thus, the single-
turnover kcat determined under these conditions should reflect of the slowest step in the 
interval immediately following binding of enzyme and substrate through the chemical 
catalysis, i.e., potential conformational changes after binding and the cleavage of the 
isopeptide bond. The measured kcat values for all of the SCF complexes were 
approximately 1.1 sec-1, which is the same as that for N8-Cul1-Rbx1 under multi-
turnover conditions (Table 2). This suggests that either conformational change or 
proteolysis is the rate-determining step in N8-Cul1 neddylation and is not significantly 
affected by the presence of Fboxes.  
Finally, we sought to use our new set of assays to test the popular hypothesis that 
the regulation of CRL neddylation state was primarily through steric hindrance of CSN 
binding by CRL substrates. This model has some very attractive aspects because it is 
accepted that CSN should not inactivate a CRL while it is performing its proper 
enzymatic activity. Also, there was an interesting result published by Hershko and 
colleagues that showed that addition of an F-box and its substrates could maintain Cul1-
Rbx1 in a more neddylated form by the addition of Fboxes and substrates (Bornstein, 
Ganoth et al. 2006). It should be noted, however, that these experiments were done with 
relatively crude proteins fractions from lysates and that theses fractions contained 
CAND1 and neddylation machinery in addition to Cul1 and CSN. In our own work, we 
also showed that substrates had a marginal ~2-fold effect on cullin deneddylation under 
multi-turnover conditions. Our largest effect with Cylclin E-Cdk2 had the caveat that the 
substrates were still attached to a GST-tag and the status of their phospho-degron was 
unknown. Thus we set out to test what role substrates played in CSN regulation.  
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To elucidate the role of substrate in our experiments, we sought to purify a 
complex of Cyclin E/Cdk2 (EK2) that contained 100% phosphorylated degron by virtue 
of conjugating the complete degron by a sortase-mediate transpeptidation reaction. Our 
substrate was capable of being ubiquitinated in vitro, albeit slower than the short peptide 
substrate previously described (data not shown). In multi-turnover assays, our sortase-
modified version of EK2 did not decrease the rate of deneddylation of SCFFbw7, while the 
GST-EK2 behaved the same as in our previous results (Fig 5A). In fact, when we made 
more of the GST-EK2 protein and cleaved the GST tag, we found that the inhibition of 
CSN by EK2 was also lost.  
While many things can occur in complex biochemical experiments we sought to 
test the ability of EK2 to displace CSN, as has been proposed. In order to be compatible 
with our fluorescence-based assays, we made a version without a fluorophore. We carried 
out ubiquitination assays on this latter form to determine at which point our substrate was 
saturating our cullin by titrating the concentration of substrate and measuring the total 
amount of Cyclin E-Ub species until we not could appreciably see an increase in 
modified Cyclin E species. Based on this experiment, we carried out our experiments up 
to 1 µM Cyclin E-Cdk2. We titrated EK2 up to 1 µM and found that it was incapable of 
outcompeting CSN for binding to SCFFbw7 (Fig. 5B and 5C), although it was fully 
capable of being ubiquitinated by SCFFbw7. While other substrates might behave 
differently and steric obstruction by some substrates might be a means of regulating 
CSN-mediated deneddylation of specific CRLs, we concluded that perhaps given the 
heterogeneity of CRL substrates there is a distinct mechanism thay regulates CSN more 
broadly. 
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To address how CSN-mediated deneddylation of multiple CRLs might be 
regulated, we set out to find what must be a common component of all CRLs. Given that 
the role of CRLs is to modify their substrates by catalyzing the transfer of ubiquitin from 
an E2, we assumed that every substrate-bound CRL would interact with an E2-Ub unless 
otherwise regulated. Thus, we hypothesized that a bound E2 could inhibit CSN from 
deneddylating a cullin engaged in substrate ubiquitination. Three previously published 
observations provide critical support for this hypothesis: 1) Cdc34, which binds Rbx1 and 
the C-terminus of Cul1inhibits deneddylation (Emberley, Mosadeghi et al. 2012), 2) the 
E2 must come into close to proximity to the substrate to transfer the ubiquitin molecule 
and 3) after the first transfer of ubiquitin, the commitment of the substrate to 
ubiquitination, the rate of ubiquitin transfer dramatically increases until the many 
ubiquitins are added (10-15), qualifying the substrate for proteasomal degradation, and 
the E2 becomes inefficient at adding more (Pierce, Kleiger et al. 2009). It is thought that 
this is due to docking of the distal-most ubiquitin attached to substrate to a noncovalent 
‘acceptor’ binding site on Cdc34 (Petroski 2005 Cell paper). Thus we reasoned that the 
E2 enzyme might be able to sense that a substrate undergoing ubiquitination is bound to a 
CRL, precluding CSN binding until until the ubiquitinated protein dissociates.  
To test our hypothesis, we set out to determine the ability of Cdc34-Ub (oxy 
ester), which cannot transfer its conjugated ubiquitin, to inhibit deneddylation of 
SCFFbw7. For SCFFbw7 and SCFFbw7 in the presence of CycE peptide we found the Ki of 
Cdc34-Ub to be in the low micromolar range at 1.99 µM and 4.28 µM, respectively (Fig. 
6A and 6B). When we repeated this experiment with CycE peptide that was modified 
with a single ubiquitin, CycE-Ub, we found that the Ki of the reaction dropped to 565 nM 
	   87	  
(Fig. 6C). While this showed that commitment of CycE to ubiquitination does indeed 
inhibit the ability of CSN to deactivate the complex, our hypothesis would only be 
relevant if the cellular concentration of Cdc34 was not dramatically greater than 4 µM or 
lower than 565 nM. To determine the cellular concentration of Cdc34 in 293T cells, we 
quantified the concentration by mass spec with and found it to be ~500 nM (data not 
shown). Thus, in the context of the cell, the Kd of Cdc34 is approximately the same as its 
Ki for SCFFbw7-CycE-Ub, while it is 4-8-fold lower than the Ki for the same SCF not 
rapidly involved in ubiquitination.  
Discussion 
 Our investigations into the microscopic rates constants for different steps of the 
deneddylation reaction have elucidated several novel facts about the function and 
regulation of CSN. Most clearly we see that CSN does not differentiate between its own 
conformations or that of C1D in binding, since all of our measured on-rates were in the 
ballpark of the diffusion limit. Given that the off-rate of CSN from C1D appears to be 
slower than its kcat, ~1 sec-1, a majority of these interactions will lead to the deneddylation 
of the cullin, as is suggested by the near-diffusion-limited multi-turnover kcat/Kms 
previously published for both Cul1 and Cul4A (Emberley, Mosadeghi et al. 2012) 
(Lingaraju, Bunker et al. 2014). In the context of the cell, this implies that CSN is 
policing CRLs as quickly as possible by binding any available cullins and quickly 
deneddylating them.  
 As opposed to what was previously published, by others, and us that CSN could 
bind cullins tightly and be product inhibited, our data show that the binding of SCF 
complexes to CSN is incredibly dynamic. The tight affinity between CSN and its product 
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is driven by a high on-rate rather than a slow off-rate. The calculated off-rate of 4.7 sec-1 
implies that CSN:CRL complexes rapidly dissociates following deneddylation. While the 
in vitro experiments did show that CSN inhibited ubiquitination, in the context of a cell 
with other regulators cells and much higher concentrations of total CRLS (~1.2 µM) 
(Bennett, Rush et al. 2010), this may not be a significant effect. Given this insight, the 
true regulation role of CSN in regulating CRLs is still solely due to its ability to 
deneddylate cullins rather than sequester its product.  
 Our data also cast doubt on the model that cullin deneddylation is regulated by 
CRL substrates physically obstructing the binding of CSN. While this may be an 
additional mechanism for some large substrates, which bind CRLs in particular 
conformations that can interfere with CSN binding, it does not appear to be the case for 
every single one of the hundreds to thousands of heterogeneous CRL substrates. The 
results that Cdc34-Ub can recognize a substrate committed to ubiquitination and inhibit 
CSN from deneddylating Cul1-Rbx1 that is bound to a monoubiquitinated substrate, 
implies that active ubiquitination of substrates precludes CSN activity rather than the 
steric bulk of substrates themselves. According to this model, the deneddylation of every 
CRL could be regulated by this generalized mechanism regardless of its size and three-
dimensional structure, and the identity of its bound substrate. Further work is required to 
test this model in a cellular context, although these studies might prove tricky given the 
ability of multiple different E2s to ubiquitinate CRL substrates.  
 While the specificity of CSN for its substrate appears to be through affinity 
binding, its intramolecular activation appears to be highly regulated and rather complex. 
It has long been observed that unbound CSN appears to travel through the cell in an 
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autoinhibited state until forming a complex with a CRL. CSN is then rapidly activated 
such that the isopeptide bond linking Nedd8 to cullin is cleaved before the substrate can 
dissociate. Our data sheds light on why CSN is in an autoinhibtited state and how its 
activation is achieved.  
In order to reconcile the perplexing observation that E104 is both required for the 
autoinhibition of CSN, as well as the full manifestation of CSN’s catalytic activity, we 
proposed a model in which switching between active and inactive conformations of CSN 
occur stochastically and is biased by the presence of an neddylated CRL. First, we 
propose that activation/deactivation of CSN is regulated by the catalytic zinc binding 
either E104 (inactive state) or water (sandwiched between the zinc and E76; active state) 
by what we refer to as a ‘glutamate-swap’ (e-swap) mechanism. As drawn in Figure 7B, 
this hypothesis relies on three postulates: 1) that the published crystal structure is a 
representation of the low affinity, inactive conformation (State A) stabilized by the 
binding of E104 to the active site zinc 2) that binding of SCF to CSN forms the high 
affinity and active conformation (State B), in which E104 is turned away and E76 can be 
properly positioned to activate the hydrolytic water molecule and 3) that the presence of 
Nedd8 and the isopeptide bond in the active site stabilizes the high affinity, active 
conformation (State B) and precludes E104 from flipping back to bind the zinc until the 
reaction is complete and Nedd8 disassociates from the complex (State C). At this point, 
the low affinity binding between CSN and the SCF allows it to rapidly dissociate and for 
CSN to return to State A. 
Postulate 1 is supported fact that both the loss of the catalytic zinc ion and its 
reversible binding partner E104 lead to a tight binding of Cul1 (States D and E). While 
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the zinc metal is absolutely required for a functional JAMM domain an E104A mutant is 
still an active enzyme. This implies that both of these elements are required for CSN to 
return to its low affinity state, as seen in the crystal structure. Postulate 2 and 3 are 
supported by the fact that both the CSNH138A and CSNE76A appear to bind more tightly to 
N8-Cul1d as opposed to unneddylated Cul1d. Those results suggest that even with 
CSNH138A, which is generally in a high affinity state, the binding of N8-Cul1d does impart 
some, albeit relatively little, binding energy. 
The second part of our model suggests that E104 is required not only for 
maintaining the low affinity state, but also for stabilizing high affinity, active state of the 
enzyme. This hypothesis is supported by two facts. First, the single-turnover kcat implies 
that with a loss of E104, the conformational change, the catalysis or both are disfavored. 
Second, because the multi and single-turnover kcats are the same, the major reason for a 
loss in activity is due to slower catalysis. Whatever effect E104A has on the off-rate of 
CSN is not enough to render the reaction product inhibited.   
The third part of our model is that the majority of the binding energy required to 
establish the high affinity, active conformation of CSN is imparted by CSN5, in large part 
through the action of residues T103 and E104. This hypothesis is strongly supported by 
three pieces of data. First, the binding affinity of CSNΔ5 for N8-Cul1d is over an order of 
magnitude weaker than any other catalytically dead mutants, meaning it is largely 
deficient in stabilizing the high affinity conformation. Second, CSNΔ5 binds unneddylated 
cullin with less affinity than wild-type CSN, suggesting wild-type CSN5 imparts binding 
energy, and that in the presence of E104, T103 is heavily favored to remain in the low 
affinity conformation. Third, within the dynamic range of our assays, CSNΔ5 is incapable 
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of differentiating between its substrates and products. The implication of this result is that 
while other interactions between CSN and N8-Cul1 might contribute some binding 
energy, they are dwarfed compared that of the energy imparted by CSN5 and the Ins-1 
residues T103 and E104. 
The final aspect of our model for the activation of CSN is that the role imparted 
by the binding of CSN4 is significant, but marginal. Although it has been proposed that 
CSN is activated by a conformational change caused by the binding of CSN4, CSN4Δn is 
still capable of bind and catalysis. Also, we find that the affinity of CSN4Δn for Cul1d is 
significantly reduced by a factor of two, but less than that of CSN Δ5. A deletion of CSN5 
shows at least twice of an effect, implying that it contributes significantly more binding 
energy.   
Lastly, we set out to test the model that the deneddylation of CRLs is 
predominately regulated by the presence of substrate. Both our biochemical data with a 
true SCFFbw7 substrate, as well equilibrium binding data, imply that this is not the case for 
all substrate. We would like to put forth a new model based on the fact that the role of 
CRLs is to mediate substrate ubiquitination by E2s. We show that the ability of Cdc34-
Ub to inhibit deneddylation is increased once the substrate is committed to being 
ubiquitinated. Moreover, given the cellular concentrations of both cullins and Cdc34, we 
feel that this is physiologically relevant in the context of a cell.  
For decades, researchers have known the significance of CSN’s role in cell 
biology. Given the large size of CSN and its substrates, as well as their complexity, 
studying CSN has been difficult and the mechanisms of how it is regulated have been 
elusive. Through this series of experiments, we set out understand how this mysterious 
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complex is regulated. By measuring many of the individual microscopic rates of the 
reaction we are now able to gain incredible insight into its recognition of substrates as 
well as the conformation changes that regulate its activity. While there are still many 
things to learn about CSN biochemistry, including the binding partners of T103 and E104 
in the active conformation, we can now set out to study CSN role in cell biology with a 
better understanding of its function.  
Materials and Methods 
 Protein Purification and modifications CSN and all mutants were purified as 
described in (Enchev, Scott et al. 2012). Call Cullin constructs were expressed and 
neddylated as describe in (Emberley, Mosadeghi et al. 2012). EK2 was purified out of Sf9 
cells and lysed in 25 mM Tris pH 7.6, 100 mM NaCl, 5% Glycerol, 1 mM DTT, 0.5 mM 
EDTA and Roche cOmplete Protease Inhibitor Tablets. After sonications, the lysates 
were cleared at 14,000 rpm for 45 minutes at 4°C in a Sorval SS-34 rotor. The proteins 
were affinity purified with Glutathione for 3 hours at 4°C with rotation. After washing in 
batch, the tag was cleaved off by overnight Thrombin digestions. All sortase reactions 
were done at 30°C overnight in 50 mM Tris pH 7.6, 150 mM NaCl and 0.5 mM EDTA.  
 
Deneddylation Assays Deneddylation reactions were done as described in (Emberley, 
Mosadeghi et al. 2012) except that the Ovalbumin was increased to 0.1 mg/ml. Multi-
turnover assays were done with 50 nM Cullin substrate and 2 nM CSN unless otherwise 
noted. Single-turnover reactions were done with 25 nM Cullin substrates and 1 µM CSN. 
Substrates were added at 500 nM for Fig. 5A and 700 mM for Cdc34 Ki measurements.  
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Fluorescence Assays All assays were performed in a buffer containing 30 mM Tris pH 
7.6, 100 mM NaCl, 0.25 mg/ml Ovalbumin and 0.5 mM DTT. All assays were measured 
with 30 nM dansyl-labeled Cul1-Rbx1 and titrated concentrations of CSN. Equilibrium 
binding assays were performed on a Fluorolog-3 (Jobin Yvon) while on-rate 
measurements were performed on a Kintec Stopped-flow Apparatus. The fluorophore 
was excited at 340 nM and emissions were scanned between 450 and 600 nM, while a 
peak of 515 nM was used for the assessment of binding.  All data points were fitted to a 
quadratic (Y = M3+M4*(Kd+A+X-sqrt((Kd +30+X)^ 2-4A*X))/2*A) where A equals 
concentration of labeled protein using Prism (Graph Pad).  
 Cell Culture and Mass Spectroscopy Cells were grown in Lonza DMEM 
containing 10% FBS (Invitrogen). Transfections were done with FugeneHD per the 
manufacturers instructions (Roche). Flag-tagged CSN was inserted into a pBABE 
multiple cloning site engineered into an MSCV-GFP vector, and expressed a non-linked 
GFP. SILAC labeling was in Invitrogen DMEM containing 10% FBS and Lys8 and Arg8 
from Immunoprecipitations were done in Pierce Lysis Buffer containing cOmplete 
Protease Inhibitor Cocktail (Roche) and sonicated for 15 seconds. After a 5 minute 
clearing at 16000 rpm at 4°C, proteins were immunoprecitiates and with M2 Flag agarose 
beads (Sigma) for 30 minutes and prepared for mass spectroscopy by (Pierce, Lee et al. 
2013). Sample were run on an OrbiTrap Fusion and analyzed by MaxQuant. CRISPR 
constructs were made as described by (Shalem, Sanjana et al. 2014) 
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Figures Legends 
Figure 1. Validation of Dansy Environmental Sensitivity Assay. A) Background 
subtracted fluorescence traces of the dansyl dye bound to Cul1-Rbx1 alone or in solution 
with CSN, CAND1 or both. B) Fluorescence traces of neddylated Cul1-Rbx1 bound to 
excess Skp1/Skp2 in solution with CSNH138A, CAND1 or both. C) Titration curve of 
wild-type CSN binding to Cul1-Rbx1. D) titration curve of catalytically dead CSNE76A 
binding to Cul1-Rbx1. E) titration curve of CSNE76A binding to neddylated Cul1-Rbx1.  
 
Figure 2. Effect of Fboxes on CSN binding and kinetics.  A and B) titration curve of 
wild-type CSN binding to SCFSkp2 and SCFFbw7. C and D) Titration curve of CSNH138A 
zinc binding point mutant binding to neddylated Cul1-Rbx1. E) kobs for increasing 
concentrations of wild-type CSN and CSNH138A, binding Cul1-Rbx1 or neddylated Cul1-
Rbx1 respectively. F) kobs for increasing concentrations of CSNH138A binding to 
neddylated Cul1-Rbx1, neddylated SCFSkp2 and SCFFbw7. G) single-turnover 
deneddylation of neddylated Cul1-Rbx1, neddylated SCFskp2 and neddylated SCFFbw7.  
 
Figure 3. Cellular Asses of the Role of Ins-1. A) Western blots of 293T cell lines stably 
expressing either vector alone (GFP), flag tagged wild-type CSN5, CSN5T103I, 
CSN5E104A, CSN5T105A, or CSN5R106A lysed with 2% SDS lysis buffer. B) Western blots 
of inputs and Immunoprecipitation of flag-CSN5 constructs after 30 minute treatment 
with MLN4924. C) Efficiency of different CSN5 CRSPR constructs for decreasing 
cellular concentration of CSN5. D) SILAC ratios comparing binding partners of either 
CSN5T103I or CSN5E104A (light) to wild-type CSN5 (heavy).  
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Figure 4. Equilibrium and kinetics effects of mutating zinc chelating residues. A) 
Titration curve of CSNH138A to neddylated Cul1-Rbx1. B) Titration curve of CSNH138A 
binding to Cul1-Rbx1. C) Titration of CSNE104A binding to Cul1-Rbx1. D) Multi-turnover 
deneddylation reactions of Cul1-Rbx1 by CSNE104A or wild-type enzyme at 1 or 1.3 µM 
substrate. E) Single-turnover deneddylation of Cul1-Rbx1 by CSNE104A.  
 
Figure 5. A) Multi-turnover deneddylation of SCFFbw7 in the presence of excess EK2, 
GST-EK2 or EK2 with a sortased degron. B) Fluorescence traces of SCFFbw7 binding 
CSNH138A in the presence of increasing EK2 with a sortased degron. C) Ubiquitination of 
EK2 with a sortased degron. D) Plot of the peak absorbances of dansyl measured in 5B 
against the concentration of EK2.  
 
Figure 6. Effect of Substrate or ubiquitinated substrate of Cdc34’s ability to inhibit 
deneddylation. A) Ki of Cdc34-Ub for the inhibition of the deneddylation of SCFFbw7 
without Cyclin E peptide, with Cyclin E peptide or with mono-ubiqtuitinated Cyclin E 
peptide.  
 
Figure 7. Models incorporating the measured rates of CSN’s biochemical parameters. A) 
Model representing the microscopic rates of a deneddylation reactions. B) Model of how 
CSN switches between an inactive, low affinity state to an active, high affinity state 
through an E-swap. C) Model of how the residues in Ins-1 play a role in stabilizing both 
active and inactive conformations of CSN.  
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Table 1. Compilation of all determined binding rate constants.  
 
Table 2. Compilation of all calculated kcat.  
 
Figure S1. Controls for the Environmental Sensitivity Assay. A) Fluorescence traces of 
dansyl-conjugated Cul1-Rbx1 with or without unlabeled Cul1-Rbx1. B) Fluorescence 
traces of dansyl-conjugated to Cul1-Rbx1 with different concentrations of Ovalbumin 
carrier protein. C) Titration curves of unlabeled Cul1-Rbx1 binding to dansyl-conjugated 
Cul1-Rbx1 or N8-Cul1-Rbx1. D) Fluorescence traces of Cul1-Rbx1 in the presence of 
Cul5-Rbx2, Cul3-Rbx1, CSN or CSN and Cul3-Rbx1.  
 
Figure S2. Effect of free Nedd8 on binding Cul1-Rbx1 to wild-type CSN. Wild-type 
CSN was titrated against 30 nM Cul1-Rbx1 in the presence of 5 µM free Nedd8.  
 
Figure S3. Validation of CSN5 CRiSPR cell lines. Cells were transduced with a 
lentiviral cell virus and selected with Puromycin 
 
Figure S4. Validation of Substrates. A) Western blot of ubiquitination assay of EK2 with 
a  sortased degron without a fluorophore.. 
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Figure S3.  
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Figure S4. 
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Table 1.  
 
 
 
 
 
 
 
 
 
 
Substrate     Kd (nM)         
kon 
(x10^7 
M-1 
sec-1) 
        
koff 
(sec-1) 
(calcul
ated)) 
    
  CSN CSNH138A CSNE76A CSNΔ5 CSNE104A CSN CSN
H13
8A 
CSNE76
A CSNΔ5 CSNE104A CSN CSN
H13
8A 
CSNE76
A 
CSNΔ5 
 CSNE104A 
Cul1-
Rbx1 305 10.1 180 1180 25.8 - TBD TBD TBD TBD - TBD TBD TBD TBD 
Cul1-
Rbx1 + 
N8 
230 
- - - 
- 2 - - - - 4.7 - - - - 
N8-Cul1-
Rbx1 NA 1.64 119 1090 NA NA 2.2 TBD TBD NA NA 0.036 TBD TBD NA 
SCFSkp2 236 - - - - - - - - - - - - - - 
SCFFbw7 135 - - - - - - - - - - - - - - 
N8-
SCFSkp2 NA 2.45 - - NA NA 1.7 - - NA NA 0.042 - - NA 
N8-
SCFFbw7 NA 3.99 - - NA NA 2.8 - - NA NA 0.113 - - NA 
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Table 2.  
 
 
 
 
 
  Wild-type CSNE104A 
N8-Cul1-Rbx1 1.1 0.4 
Single-turnoever 1.1 0.4 
Multi-turnover   
N8SCFSkp2   
Single-turnoever 0.82 - 
Multi-turnover - 
N8-SCFFbw7   
Single-turnoever 1.0 - 
Multi-turnover - - 
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Chapter 4: Unpublished Work 
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CSN Cell Lysate Assay 
There has long been an association with CSN5 upregulation and cancer. We set 
out to develop a lysate-based assay to quantify the amount of CSN deneddylation activity 
within different cell types. Although most of this overexpression has been coupled to c-
myc associated gene amplification (the two genes are very near each other), there has 
long been an unanswered question (arising mainly form two-hybrid screen hits and 
transfection experiments) of whether CSN5 can act as a monomeric pro-oncogenic 
protein. Our goals were numerous.  We wanted to 1) quantify total CSN activity 2) 
understand whether different cell lines had different amounts of activity, 3) know 
whether activity was correlated to protein level (or a post-translation modification), 4) 
test whether overexpression of Csn5 could enhance total CSN activity, and 5) test for 
associations with disease. To this end, we developed a fluorescence polarization assay 
compatible with lysate to measure deneddylation.  
The lysates were diluted serially dilutions initial rates within the linear range of 
1.5-25 ng total protein/µl were plotted. In this way, we can compare the slope of the lines 
(Fig. 1A and 1B). To speed up the assay, they were completed before protein 
quantification was performed, and only points within the assay window were plotted. 
Comparing plate to plated, the results were highly precise (Fig. 1C). By the use of the 
JAMM domain inhibitor 8-quinolinethiol and knocking down a subunit of CSN, CSN1, 
we showed that the activity was highly specific for not just JAMM domain proteins but 
also CSN (Fig. 1D and E). On ice, the lysates could stay active over the course of hours 
(Fig 2C). The rate of deneddylation in lysates proved to be highly sensitive to both NaCl 
concentrations and pH, preferring low salt buffers at a pH of 7.5 (Fig. 2A and B).  We did 
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not tirate below 50 mM, which gave the fast rates, but without salt, the assay the activity 
of reduced (data not shown). We also showed by use of an ATP regenerating enzyme, 
that our assay could be used to also study neddylation, which was easily inhibited by the 
neddylation inhibitor MLN4924 (Fig. 2D and 2E).  
Through our assays we found that CSN activity as compared to total protein 
varied to different extents among different cell lines (Fig. 3A-D). This change in activity 
either completely, or partially corrected by normalizing to CSN1 or CSN5 by western 
blots. Also, the T antigen in used in 293T did not have an effect on CSN activity, nor did 
overexpression of CSN5 alone. 
 
Von Hippel Lindau Protein (VHL) 
During the course of trying to find a cell-based assay we turned to other cullins 
and fell across some very interesting results with VHL. We first discovered that in cell 
lysates, one must always control for both neddylation and deneddylation even at 4°C. Our 
results showed that cullins bound to both VHL or a truncation mutant incapable of 
binding its substrate Hif1α could be both fully neddylated or deneddylated during an hour 
IP (Fig. 5A and 5B). We also noticed that in the absence of substrate, substrate receptors 
bound far less cullin (Fig. 5B), implying that substrates might play some role in complex 
assembly. This will be discussed later in this section.  Beyond substrates, we used a cullin 
incapable of binding substrate receptors and found that they too were capable of being 
both neddylated and deneddylated, implying that substrate and substrate receptors are not 
required per se for this pathway.  
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VHL disease itself is broken down into several forms of diseases. Type 1 is 
caused by deletion or a loss of substrate binding, leads to massive Hif1α stabilization and 
multiple cancers including renal cell carcinoma (RCC) and hemanigoblastomas, but does 
not lead to pheochromocytomas. Type 2 diseases have varying levels of binding and 
ubiquitination and thus different risks for RCC and hemangioblastomas, but all (2A, 2B 
and 2C) do lead to pheochromocytomas. VHL Type 2C, which barely stabilized Hif1α 
only leads to pheochromocytomas. This finding that loss of substrate binding or deletion 
does not lead to pheochromocytomas, but that mild missense mutations do implies that 
pheochromocytomas are caused by gain of function of the VHL mutations.  
Since VHL is a tumor suppressor, we used this set of mutations to test whether we 
could find interesting mutations since this is a mutational hotspot. What we found 
surprisingly was that certain mutations designed to ablate binding to substrate, led to 
hyperneddylation (Fig. 5D)! They all were also Type 2 mutations, implying that through 
some mechanism, either disrupting normal Cul2 cycling or through degrading a 
neosubstrates, Type 2 disease mutations are causing pheochromocyotmas.  
Substrate and CAND1’s Roles in Neddylation and Fbox Exchange 
Two insights led us to take on the next set of experiments. First, was the 
published result that CAND1 is an exchange factor, which can exchange substrate 
receptors on non-neddylated cullins. Second was our VHL result that substrate receptors 
incapable of binding their substrates were significantly less bound to cullins. Our 
assessment was that perhaps substrate played a role in CAND1-meadiated bound 
exchange. Perhaps CAND1 could sense a CRL was bound to a substrate and would thus 
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not exchange its substrate receptor, but rather exchange empty substrate receptors to 
allow substrate bound ones an opportunity to bind a cullin.  
While we knew that in the absence of CSN and CAND1, fboxes and substrates 
had no effect on the rate of neddylation (unpublished data), we knew that Fbox proteins 
could relieve CAND1 mediated inhibition of neddylation (Pierce, Lee et al. 2013). First, 
we attempted to test this theory by pulling down Cul1 and seeing how much TAMRA-
labeled Fbw7 could be pulled down (Fig. 6A). In the presence of CAND1, we bound less 
Fbw7, which was further diminished by the addition of a competing Fbox, Skp2. Exactly 
as suspected, the addition of Fbw7’s substrate CyclinE/Cdk2 (EK2) partially overcame 
the effects of Skp2 and CAND1, implying that an Fbox bound to a substrate would be 
more likely to bind Cul1 in the presence of CAND1 as opposed to one which was 
unbound. We next attempted to neddylate Cul1-Rbx1 and SCFFbw7 in the presence of 
CAND1 with or without EK2 (Fig. 6A). We found that while Cul1-Rbx1 could not be 
neddylated, even in the presence of substrate (data not shown), that EK2 could increase 
the rate of neddylation by about two-fold. Although these effects are modest, they lend 
support for the idea that substrates can affect CAND1 function and thus provide a 
potential mechanism by which CRL complex assembly can be mediated.  
In our control experiments for neddylation, we tested a few extra conditions. 
What we found while attempting to both neddylate and deneddylate was that regardless 
of substrate being around or not, CSN inhibited neddylation. Surprisingly, CAND1 
actually relieved the inhibition of neddylation by CSN (Fig. 7A). This made us think that 
CAND1 could act as a Neddylation Priming Factor (NPF). We knew from the 
development of our assay in chapter three that CAND1 can out compete CSN for Cul1 
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binding but that Fboxes bind with CSN in a complex. Thus we assayed whether Fboxes 
could relieve CAND1’s inhibition of CSN binding. Fbw7 could in fact relieve the 
sequestering of Cul1 by CAND1 (Fig. 7B) . To finalize our hypothesis of the CRL cycle, 
we tested whether CAND1 could act as a NPF by neddylating Cul1-Rbx1 in the presence 
of CSN, CAND1 and Fbox. We found that while CAND1 did slow down neddylation on 
the millisecond time scale, it was not nearly as efficient as CSN. But interestingly, 
CAND1 in the presence of CSN behaved identically to CAND1 alone (Fig. 7C). This 
means that CAND1 was completely neutralizing CSN’s inhibition of neddylation.  
 
Materials and Methods 
All Cell lines were gown in DMEM with 10% FBS and lysed in 25 mM Tris pH 
7.6, 150 mM NaCl, 1 mM DTT and 0.2% Triton X-100 with cOmplete Protease Inhibitor 
Tablet (Roche). Lysates were then diluted 7-fold into Assay Buffer containing 25 mM 
Tris pH 7.6, 50 mM NaCl, 0.1% Triton X-100 1% Glycerol, 1 mM DTT, 25 mM 
Trehalose and 3 ng/µl Ovalbumin and then serial diluted 11 times. 5 µl of each 
concentration was mixed into a total volume of 15 µl containing 2.5 nM Cul1-Rbx1-
N8(Oregon Green). The linear range of this assay was 1.5-25 ng/µl of protein.  
All VHL IPs were done in the buffer describe by (Alexandru, Graumann et al. 
2008). Any modification in time and conditions are noted in the figures.  
Fbox competition assays were all done in 25 mM Tris pH 7.6, 100 nM NaCl, 0.5 
mg/ml Ovalbumin and 1 mM DTT. All protein concentrations were 200 nM, except for 
CycE/Cdk2, which was at 500 nM.  
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Neddylation Assays were all performed on the Kinetic Quench Flow Apparatus 
with 25 nM Tris pH 7.6, 100 nM NaCl, 12.5 mM ATP, 5 mM MgCl2 and 1 mM DTT. 
Cul1-PKA-Rbx1 was at 100 nM, while Fboxes were at 275 nM, CAND1 was at 300 nM 
CSN variants were at 300 nM and EK2 was at 500 nM. These proteins were neddylated 
with 1 µM NAE, 10 µM Ubc12 (from Sf9 cells), 300 nM DCN1 and 25 µM Nedd8.   
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Figures Legends 
Figure 1.  Validation of Fluorescence Polarization (FP) Assay of CSN in Lysate. A) 
Traces of FP over time for a serial dilutions of lysate (concentrations in A and B refer to 
dilutions not protein concentration). B) Plot of initial rates of deneddylation versus an 
arbitrary concentration. C) Plot of two technical replicates from separate plates versus 
concentration. Dilutions were made and assayed before protein concentrations were 
determined. D) Taces of FP over time. Assay was run using identical lysates +/- the 
JAMM domain inhibitor 8-thioquininol (B10). E) Plot of rates comparing control versus 
CSN1 knockdown cells to reduce level of full complex.  
 
Figure 2. Assessment of Various Conditions effecting CSN Activity. A) Rates of 
deneddylation plotted against increasing concentrations of NaCl. B) Rates of 
deneddylation plotted against pH. C) Rates of deneddylation of lysates that were placed 
on ice for varying lengths of time from 0 to 270 minutes. D and E) Traces of FP showing 
neddylation and deneddylation over time in the presence of an ATP Regenerating System 
(ARS) with or without the neddylation inhibitor MLN4924, respectively.   
 
Figure 3A. Comparing CSN Activity across cell lines. A-D) Comparison of CSN 
Activity in different cell lysates compared to 293T cell lysate. CSN1 and CSN5 refer to 
lysates of the tested cell lines normalized to either Western blots of CSN1 or CSN5 of 
293T cells.  
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Figure 4. Effect of Large T-antigen and CSN5 overexpression on CSN Activity. A) 
Plot comparing 293 and 293T cell lysates. 4) Plots comparing Control versus myc-CSN5 
overexpression in 293T cell lines.  
Figure 5. Effects of VHL Binding and Mutations on the Neddylation Status of Cul2. 
A) Western blot for Hif1α bound to immunoprecipitated Flag-VHL with or with out the 
substrate-binding domain (β domain). B) Western blot of Cul2 bound to 
immunoprecipitated Flag-VHL or mutants. IPs were done for 1 hour at 4°C with various 
inhibitors as noted in the figure. C) Western blots of Cul2 incubated with various 
inhibitors for 1 hour at 4°C as noted in the figure after lysates were cleared. D) Same B 
but with specific point mutants.  
 
Figure 6. Effect of Substrate on competition between Fboxes and CAND1 for Cul1 
Binding. 1) Pull-down of GST-Rbx1-Cul1 comparing ratio of bound and unbound 
TAMRA-Fbw7/Skp1 in the presence of CAND1, Skp2/Skp1 and CycE/Cdk2. B) Phosho-
image of the neddylation of radiolabeled Cul1-PKA-Rbx1 prebound to excess CAND1 
with or without the addition of Fbw7/Skp1 or GST-EK2. C) Quantification of B.  
 
Figure 7.  Effect of CAND1 and CSN on the Neddylation of Cul1-Rbx1. A) 
Neddylation of Cul1-PKA-Rbx1 in the presence of Fbw7/Skp1. Cul1-PKA-Rbx1 was 
prebound to wild-type CSN +/- CAND1. b) Fluorescence traces of dansyl-conjugated 
Cul1-Rbx1 in the presence of wild-type CSN and CAND1 +/- Fbw7/Skp1. 7) 
Phosphoimage of the millisecond neddylation of Cul1-PKA-Rbx1 in the presence of 
CAND1, catalytically inactive CSNH138A and Skp2/Skp1 as noted in the figure. 
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Figures 
Figure 1.  
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